Top

James A. Bankson, Ph.D.

Department of Imaging Physics, Division of Diagnostic Imaging

About Dr. James A. Bankson

Dr. Bankson leads the Magnetic Resonance Engineering Laboratory at The University of Texas MD Anderson Cancer Center, and he is Deputy Director of the Small Animal Imaging Facility. His research is focused on the use of engineering principles (RF engineering, systems engineering, electromagnetics, signal and image processing) to refine, optimize, and extend methods to characterize disease non-invasively using magnetic resonance imaging, spectroscopy, and spectroscopic imaging

Primary Appointment

Adjoint Professor, Department of Biomedical Engineering, Division of Diagnostic Imaging, The University of Texas, Austin, TX

Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Adjunct Professor, Department of Bioengineering, Rice University, Houston, TX

Keck Faculty Affiliate, The Gulf Coast Consortia, Houston, TX

Program Faculty, Department of Medical Physics Graduate Program, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Adjoint Professor, Department of Biomedical Engineering, The University of Texas, Austin, TX

Adjunct Professor, Department of Bioengineering, Rice University, Houston, TX

Keck Faculty Affiliate, The Gulf Coast Consortia, Houston, TX

Program Faculty, Department of Medical Physics Graduate Program, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX

Member, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX

Research Interests

Magnetic Resonance Imaging (MRI), Phased Arrays, Parallel MRI and fast acquisition techniques

Education & Training

Degree-Granting Education

2001	Texas A&M University, College Station, Texas, US, Electrical Engineering, Ph.D
1994	Texas A&M University, College Station, Texas, US, Electrical Engineering, BS

Postgraduate Training

2000-2002

Postdoctoral Research Fellowship, Imaging Physics, MRI, The University of Texas MD Anderson Cancer Center, Houston, Texas

Experience & Service

Academic Appointments

Associate Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017

Adjoint Associate Professor, Department of Biomedical Engineering, The University of Texas, Austin, TX, 2011 - 2017

Adjunct Associate Professor, Department of Bioengineering, Rice University, Houston, TX, 2011 - 2017

Adjoint Assistant Professor, Department of Biomedical Engineering, The University of Texas, Austin, TX, 2010 - 2011

Adjunct Assistant Professor, Department of Bioengineering, Rice University, Houston, TX, 2005 - 2011

Assistant Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2011

Instructor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2003

Administrative Appointments/Responsibilities

Member, Imaging Physics Executive Committee (IPEC), Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

Section Chief, Imaging Physics Research, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

Division Professionalism Ambassador, Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

Member, Center for Professionalism Support & Success (CPSS) Council, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

Member, Executive Research Compliance Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021

Member, Shared Resources Executive Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2022

Chair, Institutional Animal Care & Use Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2021

Member, Service Center Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019

Member, GSBS Executive Committee, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX, 2017 - 2019

Chair, Curriculum Review Committee, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX, 2017 - 2018

Chair, SpinLab Operations Committee, Department of Center for Advanced Biomedical Imaging (CABI), The University of Texas MD Anderson Cancer Center, Houston, Texas, 2017 - Present

Vice Chair, Institutional Animal Care & Use Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2018

DMR Sub-Chair, Institutional Animal Care & Use Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2017

Member, UT GSBS/MDACC Medical Physics Graduate Program Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2017

Member, Executive Committee of Graduate Studies Committee, Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, 2009 - 2011

Deputy Director, Small Animal Imaging Facility (SAIF), Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Present

Other Appointments/Responsibilities

Scientific Advisor, NVision Imaging Technologies GmbH, Ulm, Baden-Württemberg, 2022 - Present

Chair, External Advisory Committee, University of California San Francisco Hyperpolarized MRI Technology Resource Center (P41EB013598), San Francisco, CA, 2021 - Present

External Advisory Committee, University of California San Francisco Hyperpolarized MRI Technology Resource Center (P41EB013598), San Francisco, CA, 2015 - Present

External Advisory Committee, UT Southwestern NMR Center for in Vivo Metabolism (P41RR02584), Dallas, TX, 2014 - 2017

Institutional Committee Activities

Member, Search Committee for Department Chair Search, Nuclear Medicine, 2024 - Present

Member, Search Committee for Department Chair, Comparative Medicine, 2023 - 2024

Chair, Recruiting Committee, Imaging Physics, 2023

Faculty Senate Representative, Academic Policy Council, 2022 - Present

Faculty Senate Representative, Research Policy Advisory Council, 2022 - Present

Member, MD Anderson Cancer Center Faculty Senate, 2022 - Present

Member, Executive Committee of the Faculty Senate, 2022 - Present

Chair, Faculty Senate Policy Review Taskforce, 2022 - Present

Member, Research Enablement, Activities, and Conduct Team (REACT), 2021 - Present

Chair, Mid-Term Review Committee (Cynthia Lockworth), 2021

Member, Imaging Physics Governance Committee, 2020 - Present

Chair, Mid-Term Review Committee (Amer Najjar), 2020

Member, Imaging Physics Education Rubric Committee, 2020 - 2021

Member, Innovations Task Force, Division of Diagnostic Imaging, 2020

Member, DI Innovations Task Force: CABI Future Operations Subcommittee, 2020 - 2021

Member, MD Anderson Cancer Center Graduate Education Committee (GEC), 2019 - 2022

Member, MD Anderson Electronic Lab Notebook Committee, 2019 - 2022

Member, Graduate School of Biomedical Sciences Master's Degree Program Review, 2019

Member, Odyssey Program Fellowship Review Committee, 2019 - 2022

Chair, MD Anderson Cancer Center GEC Student Safety Committee, 2019 - 2022

Chair, Mid-Tenure Review Committee (Will Norton), 2019

Member, Controlled Substances Policy Committee, 2018 - 2022

Member, Department of Imaging Physics Faculty Search, 2018

Internal Grant Reviewer, INTEREST, 2017 - 2020

Grant Reviewer, CCSG Radiation Oncology and Cancer Imaging Program (ROCIP), 2017

Member, Department of Pediatrics Research Imaging Team, 2017 - Present

Member, Department of Diagnostic Radiology Abdominal Imaging Section Chief Faculty Search, 2017

Inaugural Chair, Medical Physics Candidacy Examination Committee, 2016 - 2017

Chair, Mid-Tenure Review Committee (David Fuentes), 2016

Member, MD Anderson Service Center Committee, 2015 - 2020

Member, Mid-Tenure Review Committee (Cynthia Lockhart), 2015

Member, CABI Hyperpolarization Steering Committee, 2015 - Present

Member, UT Graduate School of Biomedical Sciences (GSBS) Curriculum Review Committee, 2015 - 2018

Member, Department of Imaging Physics Faculty Search: Chief, Section of MR Physics, 2013 - 2014

Member, Division of Diagnostic Imaging Research Functional Committee, 2013 - Present

Chair, Department of Imaging Physics Ultrasound/Photoacoustic Imaging Faculty Search, 2012 - 2013

Member, UT Graduate School of Biomedical Sciences (GSBS) Alfred Knudson Outstanding Dissertation Award Committee, 2012

Member, Department of Imaging Physics Computational Biomedical Imaging Faculty Search, 2012 - 2013

Member, Institutional Animal Care and Use Committee, 2012 - 2022

Member, Department of Imaging Physics IPVL Faculty Search Committee, 2011

Member, Department of Veterinary Medicine (DVMS) North Campus Animal Resources (NCAR) Faculty Search Committee, 2011

Member, Institutional Animal Research Infrastructure Subcommittee, 2008 - 2017

Member, Small Animal Imaging Facility (SAIF) Operations Committee, 2007 - Present

Member, Small Animal Imaging Facility (SAIF) Steering Committee, 2006 - Present

Member, Small Animal Imaging Facility (SAIF) Advisory Committee, 2005 - Present

Member, Department of Imaging Physics Research Committee, 2004 - Present

Member, Small Animal Cancer Imaging Research Facility Steering-Committee, 2001 - 2006

Honors & Awards

2022	Certified Leadership Coach, The Doerr Institute for New Leaders, Rice University
2022	Distinguished Investigator Award, The Academy for Radiology and Biomedical Imaging Research
2016	Outstanding Teacher Award, International Society for Magnetic Resonance in Medicine
2015	Keynote Lecturer, Hyperpolarized MRI Technology Development Workshop, University of San Francisco
2013	Graduate, 12th Cohort of the MDACC Faculty Leadership Academy, University of Texas MD Anderson Cancer Center
2012	Dean's Commendation, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences
2005 - 2006	Certificate of Excellence in Research Mentorship, Center for Biomedical Engineering Summer Intern Program
1998	First Place Poster Competition, International Society for Magnetic Resonance in Medicine
1997	Department of Education Graduate Assistance in Areas of National Need Fellowship, Texas A&M University
1995	Competitive Graduate Scholarship, Texas A&M University - Department of Electrical Engineering
1995	Graduate Merit Fellowship, Texas A&M University, College Station, TX
1990	President's Endowed Scholarship, Texas A&M University, College Station, TX

Professional Memberships

International Coaching Federation

2022 - Present

Gulf Coast Consortia Translational Imaging Cluster

2019 - 2022

Gulf Coast Consortium for Magnetic Resonance Steering Committee

2016 - 2018

American Association of Physicists in Medicine (AAPM)

2008 - Present

Society for Molecular Imaging (SMI)

2006 - Present

The University of Texas Center for Biomedical Engineering

2003 - 2011

International Society for Magnetic Resonance in Medicine (ISMRM)

1995 - Present

Institute for Electrical and Electronics Engineers (IEEE)

1993 - Present

Selected Publications

Peer-Reviewed Articles

Chang MC, Malut VR, Mahar R, Rushin A, McLeod MA, Pierre GL, Malut IR, Staklinski SJ, Glanz ME, Ragavan M, Sharma G, Madheswaran M, Badar A, Rao AD, Law BK, Kilberg MS, Collins JHP, Kodibagkar VD, Bankson JA, DeBerardinis RJ, Merritt ME. Assessing cancer therapeutic efficacy in vivo using [2H7)]glucose deuterium metabolic imaging. Sci Adv 11(13):eadr0568, 2025. e-Pub 2025. PMID: 40138413.
McLeod M, Chang MC, Rushin A, Ragavan M, Mahar R, Sharma G, Badar A, Giacalone A, Glanz ME, Malut VR, Graham D, Sunny NE, Bankson JA, Cusi K, Merritt ME. Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD. Cell Rep Med 5(9):101714, 2024. e-Pub 2024. PMID: 39241774.
Lai SY, Sandulache VC, Schellingerhout D, Fuller CD, Chen Y, Walker CM, Bankson JA. First-in-Human Hyperpolarized MRI for Tumor Metabolism in HNSCC. JAMA Otolaryngol Head Neck Surg 150(7):628-30, 2024. e-Pub 2024. PMID: 38780963.
Larson PEZ, Bernard JML, Bankson JA, Bøgh N, Bok RA, Chen AP, Cunningham CH, Gordon JW, Hövener JB, Laustsen C, Mayer D, McLean MA, Schilling F, Slater JB, Vanderheyden JL, von Morze C, Vigneron DB, Xu D, Group HPC. Current methods for hyperpolarized [1-13C]pyruvate MRI human studies. Magn Reson Med 91(6):2204-2228, 2024. e-Pub 2024. PMID: 38441968.
Chaumeil MM, Bankson JA, Brindle KM, Epstein S, Gallagher FA, Grashei M, Guglielmetti C, Kaggie JD, Keshari KR, Knecht S, Laustsen C, Schmidt AB, Vigneron D, Yen YF, Schilling F. New Horizons in Hyperpolarized 13C MRI. Mol Imaging Biol 26(2):222-232, 2024. e-Pub 2024. PMID: 38147265.
Larson PE, Bernard JM, Bankson JA, Bogh N, Bok RA, Chen AP, Cunningham CH, Gordon J, Hovener JB, Laustsen C, Mayer D, McLean MA, Schilling F, Slater J, Vanderheyden JL, von Morze C, Vigneron DB, Xu D. Current Methods for Hyperpolarized [1-(13)C]pyruvate MRI Human Studies. ArXiv, 2023. e-Pub 2023. PMID: 37731660.
Jha PK, Walker C, Mitchell D, Oden JT, Schellingerhout D, Bankson JA, Fuentes DT. Mutual-information based optimal experimental design for hyperpolarized 13C-pyruvate MRI. Sci Rep 13(1):18047, 2023. e-Pub 2023. PMID: 37872226.
Patel RJS, Harlan CJ, Fuentes DT, Bankson JA. A Simulation of the Effects of Diffusion on Hyperpolarized [1-13C]-Pyruvate Signal Evolution. IEEE Trans Biomed Eng 70(10):2905-13, 2023. e-Pub 2023. PMID: 37097803.
Yu W, Chen Y, Putluri N, Osman A, Coarfa C, Putluri V, Kamal AHM, Asmussen JK, Katsonis P, Myers JN, Lai SY, Lu W, Stephan CC, Powell RT, Johnson FM, Skinner HD, Kazi J, Ahmed KM, Hu L, Threet A, Meyer MD, Bankson JA, Wang T, Davis J, Parker KR, Harris MA, Baek ML, Echeverria GV, Qi X, Wang J, Frederick AI, Walsh AJ, Lichtarge O, Frederick MJ, Sandulache VC. Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state. Br J Cancer 128(11):2013-2024, 2023. e-Pub 2023. PMID: 37012319.
Xu Z, Michel KA, Walker CM, Harlan CJ, Martinez GV, Gordon JW, Chen HY, Vigneron DB, Bankson JA. Model-constrained reconstruction accelerated with Fourier-based undersampling for hyperpolarized [1-13 C] pyruvate imaging. Magn Reson Med 89(4):1481-1495, 2023. e-Pub 2023. PMID: 36468638.
Kadria-Vili Y, Neumann O, Zhao Y, Nordlander P, Martinez GV, Bankson JA, Halas NJ. Gd2O3-mesoporous silica/gold nanoshells: A potential dual T1/T2 contrast agent for MRI-guided localized near-IR photothermal therapy. Proc Natl Acad Sci U S A 119(29):e2123527119, 2022. e-Pub 2022. PMID: 35858309.
Henderson L, Neumann O, Kadria-Vili Y, Gerislioglu B, Bankson J, Nordlander P, Halas NJ. Plasmonic gadolinium oxide nanomatryoshkas: bifunctional magnetic resonance imaging enhancers for photothermal cancer therapy. PNAS Nexus 1(2):140, 2022. e-Pub 2022. PMID: 36714874.
Harlan CJ, Xu Z, Walker CM, Michel KA, Reed GD, Bankson JA. The effect of transmit B1 inhomogeneity on hyperpolarized [1-13 C]-pyruvate metabolic MR imaging biomarkers. Med Phys 48(9):4900-4908, 2021. e-Pub 2021. PMID: 34287945.
Chou PC, Choi HH, Huang Y, Fuentes-Mattei E, Velazquez-Torres G, Zhang F, Phan L, Lee J, Shi Y, Bankson JA, Wu Y, Wang H, Zhao R, Yeung SJ, Lee MH. Impact of diabetes on promoting the growth of breast cancer. Cancer Commun (Lond) 41(5):414-431, 2021. e-Pub 2021. PMID: 33609419.
Chen Y, Maniakas A, Tan L, Cui M, Le X, Niedzielski JS, Michel KA, Harlan CJ, Lu W, Henderson YC, Mohamed ASR, Lorenzi PL, Putluri N, Bankson JA, Sandulache VC, Lai SY. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for solid tumors. Br J Cancer 124(10):1670-1679, 2021. e-Pub 2021. PMID: 33742144.
Michel KA, Ragavan M, Walker CM, Merritt ME, Lai SY, Bankson JA. Comparison of selective excitation and multi-echo chemical shift encoding for imaging of hyperpolarized [1-13C] pyruvate. J Magn Reson 325:106927, 2021. e-Pub 2021. PMID: 33607386.
Chen J, Patel TR, Pinho MC, Choi C, Harrison CE, Baxter JD, Derner K, Pena S, Liticker J, Raza J, Hall RG, Reed GD, Cai C, Hatanpaa KJ, Bankson JA, Bachoo RM, Malloy CR, Mickey BE, Park JM. Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate: Potential role in clinical decision making. Neurooncol Adv 3(1):vdab092, 2021. e-Pub 2021. PMID: 34355174.
Xu Z, Niedzielski JS, Sun C, Walker CM, Michel KA, Einstein SA, Martinez GV, Bankson JA. Correction and optimization of symmetric echo-planar spectroscopic imaging for hyperpolarized [1-13C]-pyruvate. J Magn Reson 321:106859, 2020. e-Pub 2020. PMID: 33160268.
Mohamed ASR, He R, Ding Y, Wang J, Fahim J, Elgohari B, Elhalawani H, Kim AD, Ahmed H, Garcia JA, Johnson JM, Stafford RJ, Bankson JA, Chambers MS, Sandulache VC, Fuller CD, Lai SY. Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study. Int J Radiat Oncol Biol Phys 108(5):1319-28, 2020. e-Pub 2020. PMID: 32712257.
Walker CM, Gordon JW, Xu Z, Michel KA, Li L, Larson PEZ, Vigneron DB, Bankson JA. Slice profile effects on quantitative analysis of hyperpolarized pyruvate. NMR Biomed 33(10):e4373, 2020. e-Pub 2020. PMID: 32743881.
Niedzielski JS, Wei X, Xu T, Gomez DR, Liao Z, Bankson JA, Lai SY, Court LE, Yang J. Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC. Acta Oncol 59(10):1193-2000, 2020. e-Pub 2020. PMID: 32678696.
Mitchell DP, Hwang KP, Bankson JA, Jason Stafford R, Banerjee S, Takei N, Fuentes D. An information theory model for optimizing quantitative magnetic resonance imaging acquisitions. Phys Med Biol 65(22):225008, 2020. e-Pub 2020. PMID: 32947269.
Harlan CJ, Xu Z, Michel KA, Walker CM, Lokugama SD, Martinez GV, Pagel MD, Bankson JA. Technical Note: A deuterated 13 C-urea reference for clinical multiparametric MRI prostate cancer studies including hyperpolarized pyruvate. Med Phys 47(7):2931-2936, 2020. e-Pub 2020. PMID: 32286689.
Ravoori MK, Singh S, Yang P, Wei W, Chen H, Ma J, Bankson JA, Kundra V. In vivo magnetic resonance imaging of orthotopic prostate cancer. Biotechniques 69(1):395-403, 2020. e-Pub 2020. PMID: 32363906.
Piotrowski SL, Wilson L, Maldonado KL, Tailor R, Hill LR, Bankson JA, Lai S, Kasper FK, Young S. Effect of Radiation on DCE-MRI Pharmacokinetic Parameters in a Rabbit Model of Compromised Maxillofacial Wound Healing: A Pilot Study. J Oral Maxillofac Surg 78(6):1034.e1-1034.e10, 2020. e-Pub 2020. PMID: 32147226.
Einstein SA, Thompson EA, Guo C, Whitley EM, Bankson JA, Cressman ENK. Application of trifluoroacetic acid as a theranostic agent for chemical ablation of solid tissue. J Vasc Interv Radiol 31(1):169-75, 2020. e-Pub 2020. PMID: 31537410.
Michel KA, Zielinski R, Walker CM, Le Roux L, Priebe W, Bankson JA, Schellingerhout D. Hyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma. Radiology 293(1):168-173, 2019. e-Pub 2019. PMID: 31385757.
Walker CM, Fuentes D, Larson PEZ, Kundra V, Vigneron DB, Bankson JA. Effects of excitation angle strategy on quantitative analysis of hyperpolarized pyruvate. Magn Reson Med 81(6):3754-3762, 2019. e-Pub 2019. PMID: 30793791.
Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V. Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol 142(3):395-407, 2019. e-Pub 2019. PMID: 30788681.
Muñoz NM, Minhaj AA, Maldonado KL, Kingsley CV, Cortes AC, Taghavi H, Polak U, Mitchell JM, Ensor JE, Bankson JA, Rashid A, Avritscher R. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma. Magn Reson Imaging 57:156-164, 2019. e-Pub 2019. PMID: 30465870.
Bader DA, Hartig SM, Putluri V, Foley C, Hamilton MP, Smith EA, Saha PK, Panigrahi A, Walker C, Zong L, Martini-Stoica H, Chen R, Rajapakshe K, Coarfa C, Sreekumar A, Mitsiades N, Bankson JA, Ittmann MM, O'Malley BW, Putluri N, McGuire SE. Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nat Metab 1(1):70-85, 2019. e-Pub 2019. PMID: 31198906.
Kirpich A, Ragavan M, Bankson JA, McIntyre LM, Merritt ME. Kinetic Analysis of Hepatic Metabolism Using Hyperpolarized Dihydroxyacetone. J Chem Inf Model 59(1):605-614, 2019. e-Pub 2019. PMID: 30602117.
Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, Bankson JA, Brindle K, Cunningham CH, Gallagher FA, Keshari KR, Kjaer A, Laustsen C, Mankoff DA, Merritt ME, Nelson SJ, Pauly JM, Lee P, Ronen S, Tyler DJ, Rajan SS, Spielman DM, Wald L, Zhang X, Malloy CR, Rizi R. Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology. Neoplasia 21(1):1-16, 2019. e-Pub 2019. PMID: 30472500.
Das S, Parga K, Chakraborty I, Tinoco AD, Delgado Y, López PM, Fernández Vega L, Sanakis Y, Ghosh S, Bankson J, Klostergaard J, González-Méndez R, Raptis RG. Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents. J Inorg Biochem 186:176-186, 2018. e-Pub 2018. PMID: 29957454.
Henderson L, Neumann O, Kaffes C, Zhang R, Marangoni V, Ravoori MK, Kundra V, Bankson J, Nordlander P, Halas NJ. Routes to potentially safer T1 magnetic resonance imaging contrast in a compact plasmonic nanoparticle with enhanced fluorescence. ACS Nano 12(8):8214-8223, 2018. e-Pub 2018. PMID: 30088917.
Jones KM, Michel KA, Bankson JA, Fuller CD, Klopp AH, Venkatesan AM. Emerging Magnetic Resonance Imaging Technologies for Radiation Therapy Planning and Response Assessment. Int J Radiat Oncol Biol Phys 101(5):1046-1056, 2018. e-Pub 2018. PMID: 30012524.
Sun CY, Walker CM, Michel KA, Venkatesan AM, Lai SY, Bankson JA. Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate. Magn Reson Med 79(6):3239-3248, 2018. e-Pub 2018. PMID: 29090487.
Zhao J, Wang H, Hsiao CH, Chow DS, Koay EJ, Kang Y, Wen X, Huang Q, Ma Y, Bankson JA, Ullrich SE, Overwijk W, Maitra A, Piwnica-Worms D, Fleming JB, Li C. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials 159:215-228, 2018. e-Pub 2018. PMID: 29331808.
Elhalawani H, Ger R, Mohamed ASR, Awan M, Ding Y, Li K, Fave X, Beers A, Driscoll B, Hormuth D, van Houdt P, He R, Zhou S, Mathieu K, Li H, Coolens C, Chung C, Bankson J, Huang W, Wang J, Sandulache V, Lai S, Howell R, Stafford J, Yankeelov T, van der Heided U, Frank S, Barboriak D, Hazle J, Court L, Kalpathy-Cramer J, Fuller C. Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180008, 2018. e-Pub 2018. PMID: 29437167.
Hua AA, Mawlawi O, Stafford RJ, Bankson J, Shao Y, Guindani M, Wendt REI. An investigation of the required MR bone attenuation correction for quantitative whole-body PET/MR Imaging using clinical NaF PET/CT studies. Int J Med Phys Clin Eng Radiat Oncol 7(3):273-95, 2018. e-Pub 2018.
Ravoori MK, Singh SP, Lee J, Bankson JA, Kundra V. In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized (13)C-Pyruvate MR Spectroscopy and (18)F-FDG PET/CT Imaging in a Mouse Model. Radiology 285(3):161772, 2017. e-Pub 2017.
Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
Marangoni VS, Neumann O, Henderson L, Kaffes CC, Zhang H, Zhang R, Bishnoi S, Ayala-Orozco C, Zucolotto V, Bankson JA, Nordlander P, Halas NJ. Enhancing T1 magnetic resonance imaging contrast with internalized gadolinium(III) in a multilayer nanoparticle. Proc Natl Acad Sci U S A 114(27):6960-6965, 2017. e-Pub 2017. PMID: 28630340.
Sandulache VC, Chen Y, Feng L, William WN, Skinner HD, Myers JN, Meyn RE, Li J, Mijiti A, Bankson JA, Fuller CD, Konopleva MY, Lai SY. Metabolic interrogation as a tool to optimize chemotherapeutic regimens. Oncotarget 8(11):18154-18156, 2017. e-Pub 2017. PMID: 28184025.
Ravoori MK, Singh S, Bhavane R, Sood AK, Anvari B, Bankson J, Annapragada A, Kundra V. Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent. Sci Rep 6:38991, 2016. e-Pub 2016. PMID: 28004770.
Benito J, Ramirez MS, Millward NZ, Velez J, Harutyunyan KG, Lu H, Shi YX, Matre P, Jacamo R, Ma H, Konoplev S, McQueen T, Volgin A, Protopopova M, Mu H, Lee J, Bhattacharya PK, Marszalek JR, Davis RE, Bankson JA, Cortes JE, Hart CP, Andreeff M, Konopleva M. Hypoxia-activated prodrug TH-302 targets hypoxic bone marrow niches in pre-clinical leukemia models. Clin Cancer Res 22(7):1687-98, 2016. e-Pub 2016. PMID: 26603259.
Walker CM, Merritt M, Wang JX, Bankson JA. Use of a Multi-compartment Dynamic Single Enzyme Phantom for Studies of Hyperpolarized Magnetic Resonance Agents. J Vis Exp(110):e53607, 2016. e-Pub 2016. PMID: 27166971.
Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell 61(4):520-34, 2016. e-Pub 2016. PMID: 26853146.
Walker CM, Chen Y, Lai SY, Bankson JA. A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS. Med Phys 43(2):854, 2016. e-Pub 2016. PMID: 26843246.
Sandulache VC, Chen Y, Skinner HD, Lu T, Feng L, Court LE, Myers JN, Meyn RE, Fuller CD, Bankson JA, Lai SY. Acute tumor lactate perturbations as a biomarker of genotoxic stress: development of a biochemical model. Mol Cancer Ther 14(12):2901-8, 2015. e-Pub 2015. PMID: 26376962.
Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, Chou PC, Rao A, Yeung SC, Lee MH, Schellingerhout D, Conrad CA, Malloy C, Sherry AD, Lai SY, Hazle JD. Kinetic modeling and constrained reconstruction of hyperpolarized 1-13C-pyruvate offers improved metabolic imaging of tumors. Cancer Res 75(22):4708-17, 2015. e-Pub 2015. PMID: 26420214.
Lee J, Ramirez MS, Walker CM, Chen Y, Yi S, Sandulache VC, Lai SY, Bankson JA. High-throughput hyperpolarized (13)C metabolic investigations using a multi-channel acquisition system. J Magn Reson 260:20-27, 2015. e-Pub 2015. PMID: 26397217.
Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Rizk N, Wen YY, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Habra M, Yang W, Pusztai L, Yeung SC, Lee MH. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming. Nat Commun 6:7530, 2015. e-Pub 2015. PMID: 26179207.
Ramirez MS, Lee J, Walker CM, Chen Y, Kingsley CV, De La Cerda J, Maldonado KL, Lai SY, Bankson JA. Feasibility of multianimal hyperpolarized (13) C MRS. Magn Reson Med 73(5):1726-32, 2015. e-Pub 2015. PMID: 24903532.
Venkatanarayan A, Raulji P, Norton W, Chakravarti D, Coarfa C, Su X, Sandur SK, Ramirez MS, Lee J, Kingsley CV, Sananikone EF, Rajapakshe K, Naff K, Parker-Thornburg J, Bankson JA, Tsai KY, Gunaratne PH, Flores ER. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature 517(7536):626-30, 2015. e-Pub 2015. PMID: 25409149.
Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V. Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One 10(6):e0131095, 2015. e-Pub 2015. PMID: 26098849.
Ng CS, Wei W, Bankson JA, Ravoori MK, Han L, Brammer DW, Klumpp S, Waterton JC, Jackson EF. Dependence of DCE-MRI biomarker values on analysis algorithm. PLoS One 10(7):e0130168, 2015. e-Pub 2015. PMID: 26208254.
Ramirez MS, Lee J, Walker CM, Sandulache VC, Hennel F, Lai SY, Bankson JA. Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla. Magn Reson Med 72(4):986-95, 2014. e-Pub 2014. PMID: 24186845.
Sandulache VC, Chen Y, Lee J, Rubinstein A, Ramirez MS, Skinner HD, Walker CM, Williams MD, Tailor R, Court LE, Bankson JA, Lai SY. Evaluation of hyperpolarized [1-¹³C]-pyruvate by magnetic resonance to detect ionizing radiation effects in real time. PLoS One 9(1):e87031, 2014. e-Pub 2014. PMID: 24475215.
Bhatnagar P, Alauddin M, Bankson JA, Kirui D, Seifi P, Huls H, Lee DA, Babakhani A, Ferrari M, Li KC, Cooper LJ. Tumor lysing genetically engineered T cells loaded with multi-modal imaging agents. Sci Rep 4:4502, 2014. e-Pub 2014. PMID: 24675806.
Flores LG, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG. Monitoring Therapy with MEK Inhibitor U0126 in a Novel Wilms Tumor Model in Wt1 Knockout Igf2 Transgenic Mice Using (18)F-FDG PET with Dual-Contrast Enhanced CT and MRI: Early Metabolic Response Without Inhibition of Tumor Growth. Mol Imaging Biol 15(2):175-85, 2013. e-Pub 2013. PMID: 22875335.
Ramirez MS, Lai SY, Bankson JA. A throughput-optimized array system for multiple-mouse MRI. NMR Biomed 26(3):237-47, 2013. e-Pub 2013. PMID: 22887122.
Ravoori M, Duggal J, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V. Visualizing the prostate gland by MR imaging in young and old mice. PLoS One 8(3):e55746, 2013. e-Pub 2013. PMID: 23469167.
Walker CM, Lee J, Ramirez MS, Schellingerhout D, Millward S, Bankson JA. A catalyzing phantom for reproducible dynamic conversion of hyperpolarized [1-13C]-pyruvate. PLoS One 8(8):e71274, 2013. e-Pub 2013. PMID: 23977006.
Zhang G, Zhang R, Melancon MP, Wong K, You J, Huang Q, Bankson J, Liang D, Li C. The degradation and clearance of Poly(N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent. Biomaterials 33(21):5376-83, 2012. e-Pub 2012. PMID: 22541356.
Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Bankson JA, Myers JN, Lai SY. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 11(6):1373-80, 2012. e-Pub 2012. PMID: 22572813.
Ragan DK, Bankson JA. Suppression of vascular enhancement artifacts through the use of a multiband, selectively spoiled radiofrequency excitation pulse. J Magn Reson Imaging 33(5):1256-61, 2011. e-Pub 2011. PMID: 21509887.
Ragan DK, Lai SY, Bankson JA. Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling. NMR Biomed 24(4):373-84, 2011. e-Pub 2011. PMID: 20862661.
Gule MK, Chen Y, Sano D, Frederick MJ, Zhou G, Zhao M, Milas ZL, Galer CE, Henderson YC, Jasser SA, Schwartz DL, Bankson JA, Myers JN, Lai SY. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res 17(8):2281-91, 2011. e-Pub 2011. PMID: 21220477.
Wang Y, Suh YA, Fuller MY, Jackson JG, Xiong S, Terzian T, Quintás-Cardama A, Bankson JA, El-Naggar AK, Lozano G. Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation. J Clin Invest 121(3):893-904, 2011. e-Pub 2011. PMID: 21285512.
Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, Thitai AK, Oh J, Volgin A, Soghomonyan S, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Mushkudiani I, Kuno N, Krishnan S, Bornman W, Lai SY, Powis G, Hazle J, Gelovani J. HIF-1 dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res 9(3):259-70, 2011. e-Pub 2011. PMID: 21364021.
Schwartz DL, Bankson JA, Lemos R, Lai SY, Thittai AK, He Y, Hostetter G, Demeure MJ, Von Hoff DD, Powis G. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Mol Cancer Ther 9(7):2057-67, 2010. e-Pub 2010. PMID: 20587661.
Koul D, Shen R, Kim YW, Kondo Y, Lu Y, Bankson J, Ronen SM, Kirkpatrick DL, Powis G, Yung WK. Cellular and in-vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. Neuro Oncol 12(6):559-69, 2010. e-Pub 2010. PMID: 20156803.
Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106(12):1904-11, 2010. e-Pub 2010. PMID: 20448213.
Serda RE, Mack A, Pulikkathara M, Zaske AM, Chiappini C, Fakhoury JR, Webb D, Godin B, Conyers JL, Liu XW, Bankson JA, Ferrari M. Cellular association and assembly of a multistage delivery system. Small 6(12):1329-40, 2010. e-Pub 2010. PMID: 20517877.
Wang S, Ren W, Liu J, Lahat G, Torres K, Lopez G, Lazar AJ, Hayes-Jordan A, Liu K, Bankson J, Hazle JD, Lev D. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Clin Cancer Res 16(9):2591-604, 2010. e-Pub 2010. PMID: 20406839.
Souza GR, Molina JR, Raphael RM, Ozawa MG, Stark DJ, Levin CS, Bronk LF, Ananta JS, Mandelin J, Georgescu MM, Bankson JA, Gelovani JG, Killian TC, Arap W, Pasqualini R. Three-dimensional tissue culture based on magnetic cell levitation. Nat Nanotechnol 5(4):291-6, 2010. e-Pub 2010. PMID: 20228788.
Ramirez MS, Esparza-Coss E, Bankson JA. Multiple-mouse MRI with multiple arrays of receive coils. Magn Reson Med 63(3):803-10, 2010. e-Pub 2010. PMID: 20146352.
Chintalgattu V, Ai D, Langley RR, Zhang J, Bankson JA, Shih TL, Reddy AK, Coombes KR, Daher IN, Pati S, Patel SS, Pocius JS, Taffet GE, Buja LM, Entman ML, Khakoo AY. Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress. J Clin Invest 120(2):472-84, 2010. e-Pub 2010. PMID: 20071776.
Ragan DK, Bankson JA. Two-point Dixon technique provides robust fat suppression for multi-mouse imaging. J Magn Reson Imaging 31(2):510-514, 2010. e-Pub 2010. PMID: 20099366.
Bai X, Yan Y, Song YH, Seidensticker M, Rabinovich B, Metzele R, Bankson JA, Vykoukal D, Alt E. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 31(4):489-501, 2010. e-Pub 2010. PMID: 20037143.
Schwartz DL, Powis G, Thitai-Kumar A, He Y, Bankson J, Williams R, Lemos R, Oh J, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Peng Z, Bornmann W, Gelovani J. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects. Mol Cancer Ther 8(4):947-58, 2009. e-Pub 2009. PMID: 19372568.
Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A. New dual-mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One 4(10):e7628, 2009. e-Pub 2009. PMID: 19893616.
Mogatadakala KV, Bankson JA, Narayana PA. Three element phased array coil for imaging of rat spinal cord at 7T. Magn Reson Med 60(6):1498-1505, 2008. e-Pub 2008. PMID: 19025892.
Dafni H, Kim SJ, Bankson JA, Sankaranarayanapillai M, Ronen SM. Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation. Magn Reson Med 60(4):822-33, 2008. e-Pub 2008. PMID: 18816866.
Altman AM, Bankson JA, Matthias N, Vykoukal JV, Song YH, Alt EU. Magnetic resonance imaging as a novel method of characterization of cutaneous photoaging in a murine model. Arch Dermatol Res 300(5):263-7, 2008. e-Pub 2008. PMID: 18305946.
Esparza-Coss E, Ramirez MS, Bankson JA. Wireless Self-Gated Multiple-Mouse Cardiac Cine MRI. Magn Reson Med 59(5):1203-6, 2008. e-Pub 2008. PMID: 18429021.
Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A novel MRI marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5-8, 2008. e-Pub 2008. PMID: 18406882.
Sankaranarayanapillai M, Tong WP, Yuan Q, Bankson JA, Dafni H, Bornmann WG, Soghomonyan S, Pal A, Ramirez MS, Webb D, Kaluarachchi K, Gelovani JG, Ronen SM. Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy method. Mol Imaging 7(2):92-100, 2008. e-Pub 2008. PMID: 18706291.
Bankson JA, Ji L, Ravoori M, Han L, Kundra V. Echo-planar imaging improves MRI evaluation of intrathoracic tumors in murine models of lung cancer. J Magn Reson Imaging 27(1):57-62, 2008. e-Pub 2008. PMID: 18058933.
Fernández A, Sanguino A, Peng Z, Ozturk E, Chen J, Crespo A, Wulf S, Shavrin A, Qin C, Ma J, Trent J, Lin Y, Han HD, Mangala LS, Bankson JA, Gelovani J, Samarel A, Bornmann W, Sood AK, Lopez-Berestein G. An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. J Clin Invest 117(12):4044-54, 2007. e-Pub 2007. PMID: 18060038.
Ramirez MS, Bankson JA. A practical method for 2D multiple-animal MRI. J Magn Reson Imaging 26(4):1162-6, 2007. e-Pub 2007. PMID: 17896362.
Ramirez MS, Ragan DK, Kundra V, Bankson JA. Feasibility of multiple-mouse dynamic contrast-enhanced MRI. Magn Reson Med 58(3):610-615, 2007. e-Pub 2007. PMID: 17763350.
Melancon MP, Wang Y, Wen X, Bankson JA, Stephens LC, Jasser S, Gelovani JG, Myers JN, Li C. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping. Invest Radiol 42(8):569-78, 2007. e-Pub 2007. PMID: 17620940.
Kundra V, Ng CS, Ma J, Bankson JA, Price RE, Cody DD, Do KA, Han L, Navone NM. In vivo Imaging of Prostate Cancer Involving Bone in a Mouse Model. Prostate 67(1):50-60, 2007. e-Pub 2007. PMID: 17031813.
Klostergaard J, Bankson JA, Uill W, Seeney CE. Magnetic vectoring of magnetically-responsive nanoparticles within the murine peritoneum. J Magn Magn Mat 311:330-335, 2007. e-Pub 2007.
Larson TA, Bankson JA, Aaron J, Sokolov KV. Hybrid plasomic magnetic nanoparticles as molecular specific bimodal MRI/Optical contrast agents. Nanotechnology 18:1-8, 2007. e-Pub 2007.
Ji X, Shao R Elliott AM, Stafford RJ, Esparza-Coss E, Bankson JA, Lian G, Z-P J, Park K, Markert JT, Li C. Bifunctional Gold Nanoshells with a Superparamagnetic Iron Oxide-Silica Core Suitable for both MR imaging and Photothermal Therapy. J Phys Chem C 111:6245-51, 2007. e-Pub 2007.
Wosik J, Xue L, L-M X, Kamel M R, Nesteruk K, Bankson JA. Superconducting array for high-field magnetic resonance imaging. Appl Phys. Lett 91(18):1803503-6, 2007. e-Pub 2007.
Orth RC, Bankson JA, Price R, Jackson EF. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced magnetic resonance imaging data using low, medium, and high molecular weight contrast agents. Magn Reson Med 58(4):705-16, 2007. e-Pub 2007. PMID: 17899608.
Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, Kundra V, Ji L. The 3p21.3 Tumor Suppressor NPRL2 Plays an Important Role in Cisplatin-Induced Resistance in Human Non-Small-Cell Lung Cancer Cells. Cancer Res 66(19):9682-90, 2006. e-Pub 2006. PMID: 17018626.
Thaker PH, Han LY, Kamat AA, Arevalo JM, TakahasLihi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, n YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and angiogenesis in ovarian carcinoma. Nat Med 12(8):939-44, 2006. e-Pub 2006. PMID: 16862152.
Ma J, Son JB, Bankson JA, Stafford RJ, Choi H, Ragan D. A fast spin echo two-point Dixon technique and its combination with sensitivity encoding for efficient T2-weighted imaging. Magn Reson Imaging 23(10):977-82, 2005. e-Pub 2005. PMID: 16376180.
Bankson JA, Stafford RJ, Hazle JD. Partially parallel imaging with phase-sensitive data: increased temporal resolution for MR temperature imaging. Magn Reson Med 53(3):658-665, 2005. e-Pub 2005. PMID: 15723414.
Walters EB, Panda K, Bankson JA, Brown E, Cody DD. Improved method of in vivo respiratory-gated micro-CT imaging. Phys Med Biol 49(17):4163-4172, 2004. e-Pub 2004. PMID: 15470930.
McNichols RJ, Kangasniemi M, Gowda A, Bankson JA, Price RE, Hazle JD. Technical developments for cerebral thermal treatment: water-cooled diffusing laser fiber tips and temperature-sensitive MRI using intersecting image planes. Int J Hyperthermia 20(1):45-56, 2004. e-Pub 2004. PMID: 14612313.
McNichols RJ, Gowda A, Kangasniemi M, Bankson JA, Price RE, Hazle JD. MR thermometry-based feedback control of laser interstitial thermal therapy at 980 nm. Lasers Surg Med 34(1):48-55, 2004. e-Pub 2004. PMID: 14755424.
Kangasniemi M, McNichols RJ, Bankson JA, Gowda A, Price RE, Hazle JD. Thermal therapy of canine cerebral tumors using a 980 nm diode laser with MR temperature-sensitive imaging feedback. Lasers Surg Med 35(1):41-50, 2004. e-Pub 2004. PMID: 15278927.
Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 100(23):13549-54, 2003. e-Pub 2003. PMID: 14597719.
Wosik J, Xie L-M, Nesteruk K, Xue L, Bankson JA, Hazle JD. Superconducting Single and Phased Array Probes for Clinical and Research MRI. IEEE Trans Applied Supercon 13(2):1050-1055, 2003. e-Pub 2003.
Bankson JA, Wright SM. Simulation-based analysis of partially parallel imaging using a linear array at high accelerations. Magn Reson Med 47(4):777-786, 2002. e-Pub 2002. PMID: 11948740.
Bankson JA, Wright SM. Multi-channel magnetic resonance spectroscopy through time domain multiplexing. Magn Reson Imaging 19(7):1001-8, 2001. e-Pub 2001. PMID: 11595372.
Bankson JA, Griswold MA, Wright SM, Sodickson DK. SMASH imaging with an eight element multiplexed RF coil array. MAGMA 10(2):93-104, 2000. e-Pub 2000. PMID: 10873199.

Abstracts

Bankson JA, Walker CM, Schellingerhout D, Chen Y, Reed B, Michel KA, Carlon S, Underwood M, Hash S, Jones J, Gonzalez J, Schuster S, Hanna E, Morrison W, Sousa L, Chariwala M, Day A, Fuller CD, Sandulache VC, Lai SY. Imaging tumor metabolism in patients with head & neck squamous cell carcinoma. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2024. e-Pub 2024.
Harlan CJ, Michel KA, Sokolov KV, Bankson JA. Development of a transmit gain calibration approach using the Bloch-Siegert shift for nonproton hyperpolarized MRI on a pre-clinical 7T scanner. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2024. e-Pub 2024.
Boyce R, Harlan C, Wang Q, Bankson J. Physiological interpretation of the AUC ratio for hyperpolarized [1-13C]-pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2024. e-Pub 2024.
Harlan CJ, Chen Y, Martinez GV, Sandulache VC, Lai SY, Bankson JA. Characterization of kpl dependence on pyruvate concentration in vitro using hyperpolarized 13C nuclear magnetic resonance. Annual Meeting of the American Association of Physicists in Medicine, 2023. e-Pub 2023.
Walker CM, He R, Xu Z, Michel K, Martinez G, Harlan CJ, Mohamed ASR, Fuller CD, Lai SY, Bankson JA. Incorporating DCE derived perfusion terms to inform fitting of hyperpolarized pyruvate metabolism in a human thyroid tumor. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2023. e-Pub 2023.
Martinez GV, Xu Z, Nevozhay D, Harlan CJ, Walker CM, Michel KA, King T, Que E, Sokolov K, Bankson JA. Initial sensitivity evaluation of a new 19F nanofurmulation at 3 Tesla using a novel human head coil. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2023. e-Pub 2023.
Harlan CJ, Chen Y, Martinez GV, Sandulache VC, Lai SY, Bankson JA. Quantitative evaluation of kpl dependence on pyruvate concentration in anaplastic thyroid cancer cell suspensions using hyperpolarized 13C NMR. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2023. e-Pub 2023.
Walker CM, Michel K, Harlan C, Xu Z, Martinez G, Schellingerhout D, Lai S, Bankson JA. Flow effects on spatial spectral excitation of hyperpolarized agents. Joint Annual Meeting of the International Society for Magnetic Resonance and European Society for Magnetic Resonance in Medicine and Biology, 2022. e-Pub 2022.
Martinez G, Nevozhay D, Bournat J, Cheng D, Sharma A, King T, Que E, Gopalakrishnan V, Sokolov K, Bankson JA. Optimization of a highly sensitive 19F MRI probe for NK cell immunotherapy tracking. Joint Annual Meeting of the International Society for Magnetic Resonance and European Society for Magnetic Resonance in Medicine and Biology, 2022. e-Pub 2022.
Harlan C, Niedzielski J, Michel K, Chen Y, Martinez G, Lorenzi P, Tan L, Merrit M, Ragavan M, Sandulache V, Lai S, Bankson JA. Quantitative evaluation pf pyruvate uptake and metabolism in cells using mass spectroscopy and hyperpolarized 13C NMR. Joint Annual Meeting of the International Society for Magnetic Resonance and European Society for Magnetic Resonance in Medicine and Biology, 2022. e-Pub 2022.
Michel K, Harlan C, Mitcham T, Bouchard R, Merritt M, Bankson J. Effects of blood oxygen content on longitudinal relaxation of hyperpolarized 13C agents at 7T. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2021. e-Pub 2021.
Xu Z, Walker C, Harlan C, Michel K, Martinez G, Bankson J. Constrained UNFOLD (CoUNFOLD)- a new model-based constrained reconstruction for hyperpolarized 13C pyruvate imaging. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2021. e-Pub 2021.
Harlan CJ, Xu Z, Walker CM, Michel KA, Reed GD, Bankson JA. The effect of transmit B1 inhomogeneity on hyperpolarized [1-13C]-pyruvate metabolic MR imaging biomarkers. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2021. e-Pub 2021.
Patel RJS, Harlan CJ, Bankson JA. Simulating the effects of diffusion on hyperpolarized [1-13C]-pyruvate signal evolution. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2021. e-Pub 2021.
Walker CM, Xu Z, Michel K, Marintez G, Harlan C, Carlon S, Williams S, Willis B, Gonzales J, Hash S, Jones J, McCoy A, Willis B, Underwood M, Day A, Chariwala M, Le D, Waligorsky G, Schellingerhout D, Lai SY, Bankson JA. Imaging treatment response with hyperpolarized pyruvate in anaplastic thyroid carcinoma. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2021. e-Pub 2021.
Michel K, Walker C, Merrit M, Bankson J. Comparison of selective excitation and IDEAL for chemical shift imaging of hyperpolarized [1-13C]-pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2020. e-Pub 2020.
Mohamed A, He R, Ding Y, Wang J, Fahim J, Elgohari B, Elhalawani H, Johnson J, Stafford J, Bankson J, Chambers M, Sandulache V, Fuller C, Lai S. Prospective assessment of DCE-MRI parameters associated with advanced mandibular osteoradionecrosis after IMRT of head and neck cancer. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2020. e-Pub 2020.
Bankson JA, Michel KA, Xu Z, Harlan CJ, Martinez G, Walker CM. The filtering effect of signal excitations on hyperpolarized imaging agents. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2020. e-Pub 2020.
Harlan CJ, Xu Z, Michel KA, Walker CM, Lokugama SD, Pagel MD, Bankson JA. A deuterated 13C-urea reference to eliminate 1H imaging artifacts in hyperpolarized 13C MRI studies. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2020. e-Pub 2020.
Mitchell D, Hwang K, Stafford RJ, Bankson J, Fuentes D. Calibration of synthetic MRI acquisition parameters through information theory modeling. Annual Meeting of the American Association of Physicists in Medicine, 2019. e-Pub 2019.
Thompson E, Einstein S, Bankson J, Cressman E. Linearity of R1 with temperature in trifluoroacetate: development of fluorine-19 MRI thermometry for thermochemical ablation. Annual Meeting of the American Association of Physicists in Medicine, 2019. e-Pub 2019.
Michel K, Walker C, Merritt M, Bankson J. Optimization of spatial and spectral encoding for hyperpolarized [1-13C]-pyruvate MRI. Annual Meeting of the American Association of Physicists in Medicine, 2019. e-Pub 2019.
Niedzielski J, Wei X, Xu T, Gomez D, Liao Z, Bankson J, Lai S, Court L, Yang J. Impact of cardiac substructure dose for modeling radiation toxicity in the heart. Annual Meeting of the American Association of Physicists in Medicine, 2019. e-Pub 2019.
Michel K, Munoz N, Maldonado K, Bankson J, Sun J, Qayyum A, Avritscher R. Blood oxygen level dependent MRI detects changes in hepatocellular carcinoma induced by sorafenib treatment. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Xu Z, Niedzielski J, Michel K, Walker C, Einstein S, Bankson J. Symmetry Preserved Rectilinear Transform (SPRT): Optimized Reconstruction of Echo Planar Spectroscopic Image for Hyperpolarized [1-13C]-Pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Einstein S, Thompson E, Guo C, Whitley E, Cressman E, Bankson J. Evaluation of trifluoroacetic acid as a theranostic fluorine-19 MRI agent for chemical ablation of solid tissue. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Ragavan M, Carter A, Downes G, Giacalone A, Michel K, Bankson J, Merritt M. Binomial Excitation for Detection of Hyperpolarized [2-13C] Dihydroxyacetone Metabolism. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Mitchell D, Fuentes D, Stafford J, Bankson J, K-P H. Information Quantification of Subsequent Acquisitions for Minimizing Synthetic MRI Reconstruction Uncertainty. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Walker C, Bankson J. Multi-Slice Correction for Metabolic Rate Quantification of Hyperpolarized Pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Ragavan M, Carter A, Downes G, Giacalone A, Michel K, Bankson J, Merritt M. Hyperpolarized Dihydroxyacetone Metabolism in the Mouse Liver Under Physiological Perfusion Conditions. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2019. e-Pub 2019.
Michel K, Walker C, Niedzielski, Chen Y, Lai S, Ravoori M, Kundra V, Merritt M, Bankson J. Design and implementation of a flexible imaging sequence for pre-clinical hyperpolarized 13C MRI. Annual Meeting of the American Association of Physicists in Medicine, 2018. e-Pub 2018.
Walker CM, Bankson J. Effects of non-ideal spectral-spatial excitation slice profile on quantitative analysis of metabolism using hyperpolarized pyruvate. Annual Meeting of the American Association of Phyicists in Medicine, 2018. e-Pub 2018.
Niedzielski J, Bankson JA, Michel K, Walker C, Chen Y, Lai S. Analysis of pharmacokinetic modeling and doxyxycline to quantify tumor metabolism variations using hyperpolarized [1-13C]-pyruvate MRI. Annual Meeting of the American Association of Physicists in Medicine, 2018. e-Pub 2018.
Thompson E, Einstein S, Bankson J, Cressman E. Chemoablation agent imaging with background-free 19F-MRI. Annual Meeting of the American Association of Physicists in Medicine, 2018. e-Pub 2018.
Niedzielski J, Xu Z, Sun CY, Michel KA, Walker CM, Einstein S, Bankson JA. Optimization of radial echo planar spectroscopic image reconstruction for hyperpolarized [1-13C]-pyruvate imaging. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2018. e-Pub 2018.
Walker CM, Bankson JA. Slice profile induced errors in metabolic quantification of hyperpolarized pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2018. e-Pub 2018.
Sun C-Y, Walker CM, Michel KA, Bankson JA. Radial spectroscopic imaging of hyperpolarized [1-13C]-pyruvate. GE In-Kind Spring Symposium: Collaborative Innovations in Imaging Research, 2017. e-Pub 2017.
Walker CM, Lee J, Campbell A, Gonzalez-Lepera C, Bhattacharya P, Bankson J, Kundra V. Metabolic imaging of prostate cancer patients for monitoring therapeutic efficacy. GE In-Kind Spring Symposium: Collaborative Innovations in Imaging Research, 2017. e-Pub 2017.
Munoz NM, Minhaj AA, Maldonado KL, Kingsley C, Nishiofuku H, Michel KA, Cortes AC, Bankson JA, Rashid A, Avritscher R. Imaging tumor heterogeneity after multikinase inhibitor therapy in rat hepatocellular carcinoma. Annual Meeting of the American Association for Cancer Research, 2017. e-Pub 2017.
Bankson JA, Michel KA, Walker CM, Chen Y, Delacerda J, Kingsley C, Lorenzi PL, Tan L, Lai SY. A preliminary framework for validation of HP MRI using mass spectrometry. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2017. e-Pub 2017.
Michel KA, Walker CM, Chen Y, Delacerda J, Lai S, Bankson JA. Simulation of hyperpolarized perfusion MRI with a segmented snapshot acquisition. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2017. e-Pub 2017.
Walker CM, Michel KA, Zielinkski RJ, Priebe W, Schellingerhout D, Bankson JA. Combined hyperpolarized pyruvate and lactate as a proxy for hyperpolarized urea to measure tissue perfusion. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2017. e-Pub 2017.
Sun C, Walker CM, Michel KA, Bankson JA. Effects of fit degrees of freedom on pharmacokinetic analysis. Experimental Nuclear Magnetic Resonance Conference, 2017. e-Pub 2017.
Michel KA, Walker CM, Chen Y, Delacerda J, Lai S, Bankson JA. Simulation of hyperpolarized perfusion MRI with a segmented snapshot acquisition. Experimental Nuclear Magnetic Resonance Conference, 2017. e-Pub 2017.
Walker CM, Bankson JA. Instantaneous excitation loss modeling can improve metabolic quantification of hyperpolarized pyruvate. Experimental Nuclear Magnetic Resonance Conference (ENC), 2017. e-Pub 2017.
Bankson JA. Quantitative Imaging of Tumor Metabolism Using Hyperpolarized Pyruvate. Department of Cancer Systems Imaging Symposium on Metabolism in Cancer. Houston, TX, 2016. e-Pub 2016.
Walker CM, Bankson JA. Evaluation of Excitation-Angle Error Effects on Qualification of Hyperpolarized Pyruvate. World Molecular Imaging Congress, 2016. e-Pub 2016.
Sun C, Walker CM, Bankson JA. Assessment of Parameter Sensitivity in Parmacokinetic Analysis of the Hyperpolarized Pyruvate. World Molecular Imaging Congress, 2016. e-Pub 2016.
Sunc C, Walker CM, Bankson JA. The Effects of Noise on Pharmacokinetic Analysis of the Apparent Conversion of Hyperpolarized Pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2016. e-Pub 2016.
Walker C, Bankson J. A novel Bloch-McConnell simulator for perfused hyperpolarized substrates. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2015. e-Pub 2015.
Bankson JA, Walker CM, Chen Y, Lai SY, Hazle JD. Metabolic imaging with hyperpolarized [1-13C]-pyruvate and DCE-MRI. American Association of Cancer Researchers Special Conference on Metabolism in Cancer, 2015. e-Pub 2015.
Bankson J, Walker C, Stefan W, Fuentes D, Merritt M, Chen Y, Malloy C, Sherry D, Lai S, Hazle J. Model-Based Reconstruction of Hyperpolarized [1-13C]-Pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2015. e-Pub 2015.
Wosik J, Nesteruk K, Tan IC, Qin K, Bankson JA. Cryogenic Receive-only 7T Coil for MRI of Hyperpolarized 13C. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2015. e-Pub 2015.
Walker CW, Bankson JA. A Bloch-McConnell simulator with pharmacokinetic modeling to explore accuracy and reproducibility in the measurement of hyperpolarized pyruvate. Proc. SPIE Medical Imaging, Orlando, FL, Feb 2015, 2015. e-Pub 2015.
Bankson JA. Metabolic MRI using Hyperpolarized Substrates. Department of Cancer Systems Imaging 3rd Annual Symposium on Metabolism in Cancer, Houston, TX, Sept 2014, 2014. e-Pub 2014.
Walker CM, Ramirez MS, Lee J, Bankson JA. A multi-compartment phantom for controlled and heterogeneous conversion of hyperpolarized [1-13C]-pyruvate to lactate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2014. e-Pub 2014.
Ramirez MS, Lee J, Chen Y, Walker CM, Lai SY, Bankson JA. Multi gradient and spin-echo radial acquisition for hyperpolarized 13C MRSI. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2014. e-Pub 2014.
Ramirez MS, Lee J, Venkatanarayan A, Flores ER, Bankson JA. Dynamic hyperpolarized 13C MRS in a spontaneous mouse model of thymic lymphoma. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2014. e-Pub 2014.
Ramirez MS, Lee J, Walker CM, Sandulache VC, Lai SY, Bankson JA. Improved throughput for preclinical hyperpolarized 13C MRS. World Molecular Imaging Congress, 2013. e-Pub 2013.
Ramirez MS, Walker CM, Lee J, Sandulache VC, Chen Y, Lai SY, Bankson JA. A robust, semi-quantitative imaging strategy for hyperpolarized MRI. World Molecular Imaging Congress, 2013. e-Pub 2013.
Zhao J, Vykoukal J, Abdelsalam M, Javadi S, Bankson J, Wallace M, Avritscher R, Melancon MP. Adipose-derived stem cells labeled with SPIO-coated hollow gold nanoshells as theranostic approach for liver injury. Society for Interventional Radiology, 2013. e-Pub 2013.
Ramirez MS, Lee J, Sandulache V, Walker CM, Chen Y, Lai SY, Bankson JA. Projection acquisitions for dynamic hyperpolarized 13C MRI. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2013. e-Pub 2013.
Lundquist CM, Loo CH, Mack A, Gu J, Bankson JA, Serda R. Porous silicon-superparamagnetic iron oxide complexes and impact on negative contrast enhancement in MRI. American Society for Mechanical Engineers Global Congress on Nanoengineering for Medicine and Biology, 2013. e-Pub 2013.
Bhatnagar P, Alauddin M, Bankson JA, Kirui D, Huls H, Lee DA, Li KC, Cooper LJN. Multi-modal imaging of T cells genetically engineered for human application. American Society for Mechanical Engineers Global Congress on Nanoengineering for Medicine and Biology, 2013. e-Pub 2013.
Sandulache VC, Chen Y, Lee J, Ramirez MS, Skinner HD, Court LE, Bankson JA, Lai SY. Using hyperpolarized magnetic resonance (HP-MR) to monitor solid tumor progression, metastasis, and response to treatment. AACR Translational Impact of Model Organisms in Cancer, 2013. e-Pub 2013.
Walker CM, Lee J, So J, Schellingerhout D, Bankson J. A single-enzyme dynamic hyperpolarized phantom. CPRIT Innovations in Cancer Prevention and Research Conference, 2012. e-Pub 2012.
Ramirez MS, Lee J, Bankson JA. A radial acquisition scheme for dynamic MRI of hyperpolarized 13C. CPRIT Innovations in Cancer Prevention and Research Conference, 2012. e-Pub 2012.
Bankson JA, Lee J, Phan L, Chen Y, Ramirez M, P-C C, Schellingerhout D, Sandulache VC, S-C Y, M-H L, Lai SY, Conrad C, Hazle J. Modeling and quantitative evaluation of hyperpolarized [1-13C]-pyruvate. CPRIT Innovations in Cancer Prevention and Research Conference, 2012. e-Pub 2012.
Bankson JA, Sandulache VC, Chen Y, Merritt M, Lai SY, Hazle JD. Tumor perfusion correlates with hyperpolarized lactate in a murine model of thyroid cancer. World Molecular Imaging Congress, 2012. e-Pub 2012.
Ramirez MS, Chen Y, Lai SY, Bankson JA. A six-fold throughput improvement for preclinical cancer studies. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2012. e-Pub 2012.
Bankson JA, Sandulache VC, Merritt ME, Elliott AM, Chen Y, Priebe W, Schellingerhout D, Lai SY, Conrad CA, Hazle JD. Dynamic spectroscopy and modeling of response to 2-deoxyglucose using hyperpolarized [1-13C]-pyruvate. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2012. e-Pub 2012.
Sandulache V, Bankson JA, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Hazle JD, Myers JN, Lai SY. In vivo monitoring of metabolic inhibition in anaplastic thyroid carcinoma. Annual Meeting of the American Association of Cancer Researchers, 2012. e-Pub 2012.
Bankson JA, Sandaluche V, Merritt M, Elliott A, Chen Y, Priebe W, Schellingerhout D, Lai SY, Conrad C, Hazle JD. Dynamic spectroscopy and modeling of hyperpolarized [1-13C]pyruvate in response to 2-Deoxyglucose. CPRIT Innovations in Cancer Prevention and Research Conference, 2011. e-Pub 2011.
Bankson JA, Merritt M, Elliott A, Ramirez M, Chen Y, Lai SY. Dynamic Spectroscopy and Modelling of Hyperpolarized [1-13C]-Pyruvate in an Oterhotopic Model of Thyroid Cancer. World Molecular Imaging Congress, 2011. e-Pub 2011.
Ramirez MS, Bankson JA. A 20-coil array system for parallel-imaging accelerated multiple-mouse MRI. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2011. e-Pub 2011.
Lai SY, Chen Y, Gule M, Lemos R, Myers NH, Schwartz DL, Bankson JA. Comparing response to therapy using a multi-animal dual-tracer DCE-MRI platform. World Molecular Imaging Congress, 2010. e-Pub 2010.
Lai SY, Chen Y, Lemos R, Myers JN, Schwartz D, Bankson J. Preclinical assessment of therapeutic agents for thyroid cancer using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). International Thyroid Congress, 2010. e-Pub 2010.
Ramirez MS, Bankson JA. Selection and verivication of a throughput-optimized receiver array for multiple-mouse DCE-MRI. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2010. e-Pub 2010.
Bankson JA, Schwartz DL, Webb D, Kingsley CV, Delacerda J, Ramirez MS, Powis G. Preclinical therapeutic sequencing using a dual-tracer multi-animal DCE-MRI platform. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2010. e-Pub 2010.
Ragan DK, Lai SY, Bankson JA. In vivo measurement of pharmacokinetic parameters in small animal DCE-MRI using cardiac sampling of the vascular input function. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2010. e-Pub 2010.
Chen Y, Gule M, Lemos R, Myers JN, Schwartz DL, Bankson J, Lai SY. Evaluation of vandetanib (ZD6474) and radiation therapy in an orthotopic xenograft model of anaplastic thyroid carcinoma. Annual Meeting of the American Association of Cancer Researchers, 2010. e-Pub 2010.
Lai SY, Chen Y, Gule M, Lemos R, Myers JN, Schwartz DL, Bankson J. A preclinical model for the assessment of targeted therapy efficacy in thyroid cancer. ASTRO-AHNS-ASCO Multidisciplinary Head and Neck Cancer Symposium, 2010. e-Pub 2010.
Powis G, Von Hoff D, Bankson J, Lemos R, Hostetter G, Demeure M, Schwartz D. Enhanced anti-tumor activity of the HIF-1 inhibitor PX-478 combined with radiation and chemotherapy in pancreatic cancer. AACR-NCI-EORTC International Conference on Molecular Targets and Therapeutics, 2009. e-Pub 2009.
Alvarez, RH, Valero V, Hortobagyi GN, Bassett RL, Lu C, Dallas N, Kiriakova G, Bankson JA, Madden TL, Ellis LM, Price JE. Mechanistic evaluation of the combination effect of paclitaxel and bevacizumab in breast cancer xenografts. American Society of Clinical Oncology, 2009. e-Pub 2009.
Ramirez MS, Bankson JA. Resonance Shift Decoupling: A Potential Alternative to Low Input Impedance Preamplifiers. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2009. e-Pub 2009.
Ragan DK, Bankson JA. ABCDEFGHI: Anatomic Basis Construction for Dynamic Enhancement Following Gadolinium cHelate Injection. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2009. e-Pub 2009.
Ng CS, Bankson JA, Kundra V, Waterton JC, Jackson EF. Reproducibility and Cross-Validation of DCE-MRI and DCE-CT Perfusion Parameters in a Rat Tumor Model. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2009. e-Pub 2009.
Marsh R, Terry N, Bankson J, Hazle J. Quantitative in vivo measurement of treatment response in murine tumors using diffusion-weighted magnetic resonance imaging. Annual Meeting of the American Association of Physicists in Medicine, 2008. e-Pub 2008.
Ramirez MS, Bankson JA. Multiple-mouse MRI with multiple arrays of receive coils (MARCs). Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2008. e-Pub 2008.
Martin R, BenComo J, Martin M, JAllb B, Heard M, Kaluarachci K, Webb D, Wells N, Ibbott G. A method for extracting the relevant MRI information from normoxic polymer gels exposed to low doses. Annual Meeting of the American Association of Physicists in Medicine, 2007. e-Pub 2007.
Ronen, SM, Bankson, JA, Koul, D, Sanaranarayanapillai, M, Webb, D, Kingsley, C, Cerda D, J, Edge, J, Yung, A, Powis, G. Treatment with the novel P13K inhibitor PX-866 results in 1H MRS detectable changes in a glioma model in vivo. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Esparza-Coss E, Ramirez MS, Bankson JA. Self-Gated multi-animal Cardiac Cine Imaging. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Sankaranarayanapillai M, Bankson JA, Yuan Q, Dafni H, Webb D, Pall A, Jackson EF, Gelovani J, Tong WP, Ronen, SM. In vivo detection of histone deacetylase inhibition by MRS. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Larson T, Webb D, Sokolov KV, Bankson JA. MR Assessment of Multi-Modal Targeted Contrast Agent. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Marsh RM, Bankson JA, Patel N, Stafford RJ, Terry NHA, Hazle JD. Analysis of high b-value Diffusion Data may Highlight in vivo Cellular Changes. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Dafni H, Kim SJ, Bankson JA, Sankaranarayanapillai M, Fidler IJ, Ronen SM. Reduction in blood volume and vascular permeability induced by anti-PDGF-R therapy as detected by DCE-MRI. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Larson T, Webb D, Bankson JA, Sokolov KV. Multifunctional Plasmonic Nanoparticles for Photothermal Therapy of Cancer with MRI Monitoring. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2007. e-Pub 2007.
Melancon M, Wang Y, Jasser S, Myers J, Bankson JA, Gelovani J, Li C. Marcomolecular dual-modality MR/optical contrast agent for sentinel lymph node mapping. World Molecular Imaging Congress, 2006. e-Pub 2006.
Ramirez MS, Bankson JA. Accelerated evaluation of vascular-targeted cancer therapies via dynamic contrast-enhanced multiple-mouse MRI. World Molecular Imaging Congress, 2006. e-Pub 2006.
Bankson JA. Echo-planar MRI for Rapid Assessment of Intrahoracic Tumors in Murine Models of Lung Cancer. World Molecular Imaging Congress, 2006. e-Pub 2006.
Marsh RM, Bankson JA, Patel N, Hazle JD, Terry NHA. Magnetic Resonance Imaging, Confocal Microscopy and H&E Staining. International Society for Advancement of Cytometry (ISAC) International Congress, 2006. e-Pub 2006.
Ramirez MS, Panda K, Bankson JA. A 4-element array of volume coils for accelerated dynamic contrast-enhanced tissue modeling. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2005. e-Pub 2005.
Wosik J, Kamel KM, Nesteruk K, L-M X, Xue L, Bankson JA. Superconducting array for parallel imaging. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2005. e-Pub 2005.
Bankson JA, Ji LX, Kundra VK. Echo-planar imaging improves staging of murine model of lung cancer. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2005. e-Pub 2005.
Jackson EF, Esparza-Coss E, Bankson JA, Colon A, Patel V, Kendall R, Polverino T, Radinsky R, Starnes C. The effect of AMG 706, a novel tyrosine kinase inhibitor, on vascular permeability and blood flow as assessed by dynamic contrast enhanced magnetic resonance imaging in an in vivo preclinical tumor model. Annual Meeting of the American Society of Clinical Oncology, 2005. e-Pub 2005.
Wosik J, Xue L, Kamel M, Xie LM, Nesteruk K, Bankson JA. Superconducting Arrays for Parallel Imaging. ISMRM 2nd International Workshop on Parallel MRI, 2004. e-Pub 2004.
Wosik J, Nesteruk K, Xie LM, Xue L, Bankson JA, Naghavi M, Hazle JD. SNR Gain of Cooled Surface Coils. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2003. e-Pub 2003.
Cherukuri P, Casscells W, Willerson JT, Litovsky S, Wosik J, Xue L, Banskon JA, Yuan C, Naghavi M. Contrast Enhanced Intravascular Detection of Vulnerable Plaque using SPIO and a Novel MRI Catheter. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2003. e-Pub 2003.
Ma J, Bankson JA, Stafford RJ. Multipoint Dixon Imaging using Sensitivity Encoding. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2003. e-Pub 2003.
Bankson JA. Computer Aided Design of SENSE Arrays for Small-Animal Imaging. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2003. e-Pub 2003.
Hirsh LR, Stafford RJ, Bankson JA, Sershen SR, Price, RE, Hazle, JD, Halas, NJ, West, JL. Targeted photothermal tumor therapy using metal Nanoshells. Joint Annual Conference of the Engineers in Medicine and Biology Society (EMBS) and Biomedical Engineering Society (BMES), 2002. e-Pub 2002.
Wright SM, Porter JR, Bankson JA, Spadea JR. Magnetic Resonance Imaging with Large Sensor Arrays. Annual Meeting of the Biomedical Engineering Society, 1996. e-Pub 1996.
Bankson JA, Wright SM. On the Use of Time Domain Multiplexing for MR Spectroscopy. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 1996. e-Pub 1996.
Wright SM, Porter JR, Bankson JA, Spadea JR. Phased Array Coils for Functional MR Imaging. Annual Meeting of the Houston Society for Engineering in Medicine and Biology, 1996. e-Pub 1996.
Bankson JA, Wright SM, Reykowski A, Porter JR. Characterization of Receiver Coils for Magnetic Resonance Microscopy. Annual Meeting of the Houston Society for Engineering in Medicine and Biology, 1995. e-Pub 1995.
Wright SM, Porter JR, Boyer J, Bankson JA. Characterization of Coupling in Planar Array Coils with Arbitrary Element Geometries. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1994. e-Pub 1994.
Boyer J, Bankson JA, Reykowski A, Porter JR, Wright SM. Automated Measurement System for Characterizing RF Coils. Annual Meeting of the International Society for Magnetic Resonance in Medicine, 1994. e-Pub 1994.

Book Chapters

Kazerouni AK, Dula AN, Jarrett AM, Lorenzo G, Weis JA, Bankson JA, Chekmenev EY, Karczmar GS, Yankeelov TE. Emerging Techniques in Breast MRI. In: Breast MRI: Basic Imaging Techniques, Indications and Interpretation. Elsevier Academic Press: Cambridge, MA, 505-531, 2022.
Bankson J, Larson P. Analysis and Visualization of Hyperpolarized 13C MR Data. In: Hyperpolarized Carbon-13 Magnetic Resonance Imaging and Spectroscopy. Larson P, editor. Elsevier Academic Press: Cambridge, MA, 129-155, 2021.
Somanchi SS, Kennis BA, Gopalakrishnan V, Lee DA, Bankson JA. In vivo 19F-Magnetic Resonance Imaging of Adoptively Transferred NK Cells. In: Methods Mol Biol. Somanchi SS, ed. Springer Science + Business Media, 317-32, 2016.

Patents

Ma J, Choi, H, Stafford, RJ, Bankson, JA. Methods and Apparatus for Fast Chemical Shift Magnetic Resonance Imaging. Patent Number: USP 7358729 granted 4/15/2008.

Less

Selected Presentations & Talks

Local Presentations

2024. Professionalism and the Center for Professionalism, Support, and Success. Invited. Houston, TX, US.
2024. Hyperpolarized 129Xe MRI for Imaging Lung Function. Invited. SAIF User Meeting. Houston, TX, US.
2024. Imaging Tumor Metabolism in Patients with Hyperpolarized [1-13C]-Pyruvate MRI. Invited. ATC Retreat. Houston, TX, US.
2024. Emerging Technologies in H&N: Imaging Tumor Metabolism with HP MRI. Invited. Houston, Texas, US.
2023. Imaging Lung Function with HP 129Xe MRI. Invited. Houston, Texas, US.
2022. Clinical Translation of HP Metabolic Imaging at MD Anderson Cancer Center. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
2021. First-in-Human HP-MRI for Thyroid Cancer. Invited. Image Guided Cancer Therapy Research Program Seminar Series. Houston, Texas, US.
2021. Key Concepts for Successful Grant Submissions. Invited. Abdominal Imaging Research Retreat. Houston, Texas, US.
2020. Hyperpolarized 129Xe MRI. Invited. Houston, Texas, US.
2020. Advancing Imaging Sciences in Cancer Research. Invited. Grand Rounds, Division of Pediatrics. Houston, Texas, US.
2019. Imaging Tumor Metabolism Using Hyperpolarized MRI Agents. Invited. Image Guided Cancer Therapy Program Course: Technical Applications in Head & Neck Cancers. Houston, Texas, US.
2019. Imaging Metabolism with Hyperpolarized Pyruvate. Invited. Rice University Bioscience Ranch Collaborative. Houston, TX, US.
2019. Qualification by Complex Analysis: Embracing Complexity to Achieve Simplicity, or Zen and the Art of HP MRI. Invited. Department of Imaging Physics Research Retreat. Houston, Texas, US.
2019. A Robust Approach to Imaging Aerobic Glycolysis in Patients with Prostate Cancer. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
2019. Imaging Tumor Metabolism with Hyperpolarized [1-13C]-pyruvate,. Invited. NIH T32 Training Grant Seminar Series. Houston, Texas, US.
2019. Precision & Personalized Medicine in Radiation Oncology. Invited. Exploring Life Science Collaboration Opportunities Between Texas and Denmark. Houston, Texas, US.
2018. Shared Instrument Grants. Invited. 3rd Annual CoreTex Meeting. Houston, TX, US.
2018. Imaging Metabolism with Hyperpolarized Pyruvate. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
2017. Quantitative Metabolic MRI: Managing Noise, Error, and Bias. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
2017. Metabolic imaging of prostate cancer patients for monitoring therapeutic efficacy. Invited. Spring Symposium Collaborative Innovations in Imaging Research. Houston, Texas, US.
2016. Quantitative Imaging of Tumor Metabolism Using Hyperpolarized Pyruvate. Invited. Symposium on Metabolism in Cancer. Houston, Texas, US.
2016. Quantitative Imaging of Tumor Metabolism Using Hyperpolarized Pyruvate. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
2015. MDACC Imaging Physics Research Seminar. Invited. MDACC Institutional Grand Rounds. Houston, TX, US.
2015. Imaging tumor metabolism for indication of therapeutic response. Invited. MDACC Institutional Grand Rounds. Houston, Texas, US.
2015. Modeling and imaging strategies for hyperpolarized pyruvate. Invited. MDACC Imaging Physics Research Seminar,. Houston, Texas, US.
2015. Imaging Tumor Metabolism with Hyperpolarized Pyruvate. Invited. MDACC Cancer Metabolism Working Group. Houston, Texas, US.
2014. Imaging the Warburg Effect with Hyperpolarized Pyruvate. Invited. MDACC Institutional Grand Rounds. Houston, Texas, US.
2014. Metabolic MRI using Hyperpolarized Substrates. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
2014. Imaging the metabolism using magnetic resonance. Invited. Rice University. Houston, TX, US.
2014. The dawn of real-time metabolic and molecular magnetic resonance imaging with hyperpolarized substrates. Invited. McCombs Institute Seminar Series,. Houston, Texas, US.
2013. Preclinical metabolic imaging with hyperpolarized tracers,. Invited. Bruker Biospin MRI Annual US User’s Meeting. Houston, TX, US.
2013. Optimization of real-time metabolic scanning in anaplastic thyroid cancer cells. Invited. CPRIT/CURE Summer Training Program Poster Presentation. Houston, Texas, US.
2013. Translational MRI and Metabolic Imaging with Hyperpolarized Tracers. Invited. MDACC Institutional Grand Rounds. Houston, Texas, US.
2012. Preclinical Imaging in Cancer Research. Invited. The Methodist Hospital Research Institute Radiology Research Seminar Series. Houston, TX, US.
2010. Preclinical evaluation of response to cancer therapy. Invited. John S. Dunn Sr. Gulf Coast Consortium for Magnetic Resonance: 2010 Conference on Magnetic Resonance in Cancer Research. Houston, TX, US.
2009. Quantitative preclinical assessment of cancer therapy. Invited. Bruker Biospin MRI Annual US User's Meeting. Houston, TX, US.
2009. High-throughput preclinical quantitative MRI. Invited. Southwest Chapter of the American Association for Physicists in Medicine Annual Meeting. Houston, TX, US.
2006. Experimental MR Imaging in Oncology: an update from the Small Animal Imaging Facility. Bruker. Invited. MRI/MRS User's Meeting. Houston, TX, US.

Regional Presentations

2024. Metabolic MRI: Imaging Tumor Metabolism with Hyperpolarized [1-13C]-Pyruvate. Invited. College Station, TX, US.
2022. Modeling and analysis of hyperpolarized pyruvate for imaging tumor metabolism. Invited. UT Austin Center for Computational Oncology. Virtual, US.
2020. Translational HP MRI at MD Anderson Cancer Center. Invited. UT Southwestern NMR Center for In Vivo Metabolism Symposium and Training XXVII. Dallas, TX, US.
2017. Imaging Tumor Metabolism using Hyperpolarized Pyruvate. Invited. Texas A&M University. College Station, TX, US.
2017. Modeling and Interpretation of HP MRI. Invited. UT Southwestern Medical Center Symposium and Training XXIV. Dallas, TX, US.
2015. The Road to Imaging The Warburg Effect. Invited. UT Southwestern NMR Center for in vivo Metabolism Symposium and Training XXIII. Dallas, TX, US.
2014. Advances in Imaging of Hyperpolarized Substrates at MDACC. Invited. UT Southwestern NMR Center for in vivo Metabolism Symposium and Training XXII. Dallas, TX, US.
2013. Challenges and Opportunities for Imaging in Cancer Research. Invited. Texas A&M University. College Station, TX, US.
2013. Bruker Corporation Seminar Series: Advantages of Multiple Modalities, Imaging Fusion, and Data Analysis in Preclinical Small Animal Imaging. Invited. Bruker Corporation. Houston, Dallas, TX, US.
2013. The Promise of Hyperpolarization. Invited. UT Southwestern NMR Center for in vivo Metabolism Symposium and Training XXI: Frontiers in Molecular Imaging. Dallas, TX, US.
2012. Advanced Computing in Imaging Science and Cancer Research. Invited. The Austin Forum on Science, Technology and Society. Austin, TX, US.
2012. Progress in Quantitative Evaluation of Hyperpolarized 13C Tracers In Vivo. Invited. UT Southwestern NMR Center for in Vivo Metabolism and Training XX: Catalyzing Translational Imaging in PET an MR. Dallas, TX, US.
2011. Progress in Quantitative HP-13C Imaging. Invited. UT Southwestern NMR Center for in vivo Metabolism Symposium and Training XIX: CEST and Spectroscopy for Cancer and Other High-Impact Diseases. Dallas, TX, US.
2000. Phased Array Encoded Imaging in Magnetic Resonance. Invited. Southwest Research Institute. San Antonio, TX, US.

National Presentations

2024. Imaging Tumor Metabolism with Hyperpolarized Pyruvate. Invited. Alavi-Bradley Symposium on Molecular Imaging and Theranostics. Baltimore, MD, US.
2024. A Collection of Short Stories About Area-Under-the-Curve Ratios in HP MRI. Invited. UCSF Hyperpolarized MRI Technology Resource Center Annual Training Symposium. San Francisco, CA, US.
2023. Kinetic Modeling of Metabolic Imaging Data. Invited. NCI Co-Clinical Imaging Research Resources Program Network (CIRP). Online, US.
2023. Challenges of Setting up a New Site for HP 129Xe MRI: The MD Anderson Experience. Invited. 2023 129Xe MRI Clinical Trial Consortium. Miami, FL, US.
2022. Zen and the art of quantitative HP MRI. Invited. UCSF Hyperpolarized Carbon-13 MRI Technology Development Workshop. San Francisco, CA, US.
2022. Modeling and analysis of hyperpolarized pyruvate for MR imaging of tumor metabolism. Invited. UT Dallas Physics Colloquium. Virtual, US.
2021. Assessing Response to Therapy in Patients with Anaplastic Thyroid Cancer. Invited. UT MD Anderson Cancer Center. Virtual, US.
2018. Effects of B1 and slice profile inhomogeneitites on dynamic HP 13C MRI. Invited. University of Pennsylvania 5th International Workshop on Metabolic Imaging. Philadelphia, PA, US.
2018. Rethinking quantitative imaging with hyperpolarized substrates. Invited. WMIC Imaging in 2020. Jackson Hole, WY, US.
2018. Kinetic Modeling and Analysis of HP Signal Evolution. Invited. University of California San Francisco. San Francisco, CA, US.
2017. Developing Translational (Quantitative) Imaging Biomarkers for Cancer. Invited. Memorial Sloan Kettering Cancer Center. New York, NY, US.
2017. Imaging Hyperpolarized Substrates. Invited. Vanderbilt University Institute for Imaging Sciences Frontiers of Biomedical Imaging VI. Nashville, TN, US.
2017. Imaging Tumor Metabolism using Hyperpolarized MRI Agents, Plenary Lecture. Invited. University of Florida McKnight Brain Institute and Advanced Magnetic Resonance Imaging and Spectroscopy Facility Symposium: Magnetic Resonance Imaging and Spectroscopy: Connecting Structure and Chemistry to Function. Gainesville, FL, US.
2016. Preclinical imaging of hyperpolarized substrates. Invited. WMIC Bruker Biospin Industry Workshop: An eye on the future of imaging: cutting-edge multimodal technologies to revolutionize translational research. New York, NY, US.
2016. Quantitative analysis of hyperpolarized 13C MR. Invited. World Molecular Imaging Congress Educational Track: Quantitative Imaging. New York, NY, US.
2016. Quantification of Tumor Using Hyperpolarized Pyruvate. Invited. American Association of Physicists in Medicine Education Session. Washington, DC, US.
2016. Towards quantitative metabolic imaging with hyperpolarized substrates. Invited. University of California San Francisco. San Francisco, CA, US.
2015. Imaging Science, MRI, Biology, and Cancer Research. Invited. Massasoit Community College STEM Starter Academy. Brockton, MA, US.
2009. High Throughput Preclinical search for an improved clinical response. Invited. NCI Small Animal Imaging Resource Program Workshop. St Louis, MO, US.
2007. Small Animal Imaging at UT-MDACC. Invited. NCI Molecular Imaging Program. Bethesda, MD, US.
2007. From man to mouse to man: the story of DCE-MRI at M.D. Anderson. NCI Small Animal Imaging Resource Program Workshop. Invited. Bruker. St. Louis, MO, US.
2005. Sensitivity and Efficiency in Experimental MRI. Invited. The University of Pittsburgh Medical Center. Pittsburgh, PA, US.

International Presentations

2023. Hyperpolarizer Research & Clinical Dreams. Invited. ISMRT 2023 Educational Course. Toronto, US.
2023. Comparison of Strategies for Analysis of HP MRI Data. Invited. Bavarian Academy of Sciences and Humanities Workshop: New Horizons in Hyperpolarized 13C MRI. Munich, DE.
2022. Modeling Dynamic Metabolic Process. Invited. ISMRM 2022 Educational Course: Detecting Dynamic Metabolic Process Using Hyperpolarized 13C. London, GB.
2016. Preclinical Imaging of Hyperpolarized Substrates. Invited. World Molecular Imaging Society – An eye on the future of imaging: cutting-edge multimodal technologies to revolutionize translational research. New York City, US.
2016. Preclinical MRI in Cancer Research. Invited. University of Winnipeg. Winnipeg, CA.
2016. Imaging tumor physiology with hyperpolarized substrates. Invited. Chang Gung University: The Radiological Society of the Republic of China, TW.
2016. Preclinical MRI: Data Analysis. Invited. International Society for Magnetic Resonance in Medicine Weekend Educational Course: Preclinical Imaging, SG.
2010. High-throughput preclinical characterization of imaging biomarkers. Invited. Bruker Biospec European User’s Meeting. Ettlingen, DE.
2010. Receive Arrays. Invited. International Society for Magnetic Resonance in Medicine Weekend Educational Course: MR Engineering II, SE.
2003. Initial experiences with Bruker Biospec 47/40 USR. Invited. Bruker MRI/MRS User's Meeting. Ettlingen, DE.

Less

Grant & Contract Support

Date:	2025 - 2029
Title:	HyperCEST Imaging of Cellular Immunotherapy for Treatment of Metastatic Osteosarcoma
Funding Source:	Cancer Prevention Research Institute of Texas (CPRIT)
Role:	PI
ID:	FP00026303

Date:	2025 - 2030
Title:	Targeting Tumor Microenvironment Metabolic Alterations to Enhance Immunotherapy Efficacy in Osteosarcoma
Funding Source:	NIH
Role:	Co-I
ID:	1R01CA307048-01

Date:	2025 - 2026
Title:	Molecular Imaging of Tumor Metabolism and Perfusion to guide Immunotherapy in Ewing Sarcoma
Funding Source:	Elsa U Pardee Foundation
Role:	Co-I
ID:	FP00026372

Date:	2025 - 2027
Title:	Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5R01CA266099-03

Date:	2025 - 2030
Title:	ImpACT: Improving Treatment Strategies for Anaplastic Thyroid Cancer Through Integration of Novel Therapies and Assessment of Tumor Response
Funding Source:	NIH/NCI
Role:	Key
ID:	1P01CA302480-01

Date:	2025 - 2027
Title:	129Xe Hyperpolarized Chemical Exchange Saturation Transfer (HyperCEST) MRI for Tracking Immunotherapy Delivery in the Lungs
Funding Source:	NIH/NCI
Role:	Sponsor
ID:	1F31CA305956-01

Date:	2025 - 2030
Title:	Studying adoptive transfer of NK and CAR-NK cells against OS, either alone or in combination to improve efficacy, trafficking and persistence
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA303017-01

Date:	2025 - 2030
Title:	Metabolic reprogramming of the tumor microenvironment to enhance NK cell therapy against Osteosarcoma
Funding Source:	NIH
Role:	Co-I
ID:	1R01CA289241-01A1

Date:	2025 - 2026
Title:	Imaging tools to address metabolic changes and immune therapy response in Osteosarcoma
Funding Source:	MIB Agents
Role:	Co-I
ID:	1434239

Date:	2025 - 2027
Title:	Metabolic and perfusion changes in Ewing Sarcoma after treatment
Funding Source:	Rally Foundation
Role:	PI
ID:	FP00024753

Date:	2025 - 2026
Title:	In vivo intratumoral macrophage imaging and repolarization to enhance radiation efficacy
Funding Source:	Conquer Cancer Foundation
Role:	Mentor
ID:	FP00024071

Date:	2025 - 2028
Title:	Development of a Preclinical Magnetic Particle Imaging System Tailored for Cancer Cell Therapy
Funding Source:	National Science Foundation (NSF)
Role:	OSC
ID:	FP00024656

Date:	2025 - 2025
Title:	A Metabolic approach to improve cDCVs-mediated increased immune anti-tumor response in Osteosarcoma
Funding Source:	Elsa U Pardee Foundation
Role:	Co-I
ID:	FP00024918

Date:	2025 - 2030
Title:	Hyperpolarized Xenon-129 MRI as a predictive biomarker for mitigating radiation-induced lung injury
Funding Source:	NIH
Role:	Co-Mentor
ID:	1K23HL175243-01A1

Date:	2025 - 2026
Title:	Targeting metabolic adaptations to boost immunotherapy effectiveness in Osteosarcoma
Funding Source:	Louis B. Mayer
Role:	Mentor
ID:	FP00025214

Date:	2025 - 2026
Title:	Metabolic reprograming of the Tumor Microenvironment to enhance Natural Killer cell therapy against Osteosarcoma
Funding Source:	Texas Academy of Medicine, Engineering, Science and Technology
Role:	Co-I
ID:	FP00023038

Date:	2025 - 2026
Title:	Cryogen-Free Preclinical 7T MRI Scanner
Funding Source:	NIH/OD
Role:	PI
ID:	1S10OD038216-01

Date:	2025 - Present
Title:	Imaging Metabolic Shifts in Ewing Sarcoma Post-Therapy and its Impact on Immune Therapy Efficacy
Funding Source:	Charlie Landers Foundation
Role:	Co-I
ID:	FP00025277

Date:	2024 - 2029
Title:	Novel approach to NK cell therapy for recurrent/refractory pediatric medulloblastoma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1UG3CA297733-01

Date:	2024 - 2029
Title:	MD Anderson: Advancing Research Careers (ARC) UE5 Program
Funding Source:	NIH/NIGMS
Role:	Mentor
ID:	FP00021315

Date:	2024 - 2027
Title:	Longitudinal hyperpolarized Xenon-129 MRI as an imaging biomarker of radiation pneumonitis from lung cancer radiotherapy
Funding Source:	Department of Defense (DOD)
Role:	Co-Mentor
ID:	FP00022846

Date:	2024 - 2025
Title:	Perfluorocarbon Nanoparticles 19F MRI to Characterize Space Radiation Induced Acute Pro-Inflamm Response & Anti-Inflamm Effects of Radiation Mitigating Thrombin Peptide to Extend Healthy Life in Space
Funding Source:	Radiological Society of North America (RSNA)
Role:	Mentor
ID:	FP00021686

Date:	2024 - 2026
Title:	Cancer Center Support (CORE) Grant: Small Animal Imaging Facility
Funding Source:	NIH/NCI
Role:	Co-Director
ID:	4P30CA016672-48

Date:	2024 - 2028
Title:	Priming preclinical magnetic particle Imaging (MPI) for brain Tumor NK Cell tracking in Humans (PITCH)
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA281832-01

Date:	2024 - 2029
Title:	Hyperpolarized Xenon-129 MRI as a predictive biomarker for mitigating radiation-induced lung injury
Funding Source:	NIH/NCI
Role:	Co-Mentor
ID:	FP00020691

Date:	2024 - 2029
Title:	New approach for osteosarcoma: Enhancing and monitoring NK cell therapy
Funding Source:	NIH/NCI
Role:	Project Leader
ID:	1P01CA275719-01A1

Date:	2024 - 2029
Title:	Clinical Testing of a Magnetic Imaging Workflow for Sentinel Lymph Node Biopsy in Head and Neck Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00019645

Date:	2024 - 2029
Title:	Metabolic reprogramming of the Tumor Microenvironment to enhance NK cell therapy against Osteosarcoma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00017771

Date:	2024 - 2026
Title:	NK Immunotherapy for DIPG
Funding Source:	Children's Cancer Research Fund
Role:	Co-I
ID:	FP00020255

Date:	2024 - 2025
Title:	Preclinical Magnetic Particle Imaging System for Improved Immunotherapy
Funding Source:	NIH
Role:	Major User
ID:	1S10OD036354-01

Date:	2024 - 2025
Title:	NanoScan SPECT 4H / CT1512 / PET122S in-vivo imager
Funding Source:	NIH/NCI
Role:	Minor User
ID:	1S10OD036241-01

Date:	2024 - 2026
Title:	MPI tracking of NK Cell Immunotherapy for DIPG
Funding Source:	2023 Worldwide Cancer Research Grant
Role:	Collaborator

Date:	2023 - 2025
Title:	Development of the first clinical dual-modality MPI/CT imager
Funding Source:	Magnetic Insight, Inc
Role:	Co-I
ID:	FP00019214

Date:	2023 - 2026
Title:	Development and Harmonization of Methods for HP 13C MRI
Funding Source:	Siemens
Role:	PI
ID:	UTMDACC-2023-MR-8-01-Bankson_CLMA157530

Date:	2023 - 2025
Title:	Development of MPI for Head and Neck Cancer Sentinel Lymph Node Imaging
Funding Source:	Magnetic Insight, Inc
Role:	Co-I
ID:	FP00019065

Date:	2023 - 2028
Title:	Defeating cancer with immunomodulatory bacterial therapeutics
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	P01

Date:	2023 - 2024
Title:	In Vivo Validation of Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker for MR-Guided Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Funding Source:	American Society for Therapeutic Radiology and Oncology (ASTRO)
Role:	Other Significant Contributor

Date:	2023 - 2028
Title:	Clinical trial of NK cells for pediatric 4th ventricle brain tumors with magnetic particle Imaging (MPI) tracking
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1UG3CA283650-01

Date:	2023 - 2024
Title:	Preclinical magnetic particle Imaging (MPI) for brain Tumor NK Cell tracking
Funding Source:	Elsa U. Pardee Foundation
Role:	Co-I
ID:	20546

Date:	2023 - 2027
Title:	Characterization of Radiation Induced Oral Toxicities of the Head and Neck with Quantitative Magnetic Resonance Imaging
Funding Source:	NIH/NIDCR
Role:	Other Significant Contributor

Date:	2023 - 2028
Title:	Hyperpolarized 129Xe MRI to identify structural determinants of low lung function and respiratory symptoms in young adults from the Lung Health Cohort
Funding Source:	University of Kansas Medical Center
Role:	Co-PI
ID:	R01HL168446

Date:	2023 - 2026
Title:	Hyperpolarized 129Xe MRI for imaging NK cell therapy of lung metastasis
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	5R21CA280799-02

Date:	2023 - 2028
Title:	Multidisciplinary Predoctoral Training Program in Cancer Bioengineering
Funding Source:	NIH/NCI
Role:	Mentor

Date:	2023 - 2025
Title:	Aerosol Gemcitabine to enhance NK cell therapy against Osteosarcoma
Funding Source:	Children's Cancer Research Foundation
Role:	Co-PI
ID:	FP00017726

Date:	2022 - 2027
Title:	Metabolic imaging of patients with anaplastic thyroid cancer using hyperpolarized [1-13C]-pyruvate
Funding Source:	NIH/NCI
Role:	MPI
ID:	1R01CA269827-01A1

Date:	2022 - 2023
Title:	Novel imaging methods to predict and phenotype post-COVID interstitial lung disease
Funding Source:	Radiological Society of North America (RSNA)
Role:	Co-I
ID:	FP17327

Date:	2022 - 2027
Title:	Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer
Funding Source:	NIH/NCI
Role:	MPI
ID:	5R01CA280980-03

Date:	2022 - 2027
Title:	The Houston Center for Acquired Resistance Research (H-CARR) Project 3: Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5U54CA274321-03

Date:	2022 - 2026
Title:	HDO Imaging is a Quantitative Marker of Cerebral Glucose Oxidation
Funding Source:	NIH/NIBIB
Role:	MPI
ID:	5R01EB032376-03

Date:	2022 - 2027
Title:	New Approach for Osteosarcoma: Enhancing and Monitoring NK Cell Therapy
Funding Source:	NIH/NCI
Role:	Project Leader
ID:	1P01CA275719-01

Date:	2022 - 2027
Title:	The Stereotactic Radiology-Pathology Trial II: Prospective Imaging-Pathologic Correlation in Glioma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA266086-01A1

Date:	2022 - 2027
Title:	Image Guided Cancer Therapy Training Program
Funding Source:	NIH/NCI
Role:	Preceptor
ID:	5T32CA261856-03

Date:	2022 - 2027
Title:	Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
Funding Source:	NIH/NCI
Role:	Mentor
ID:	5T32CA196561-08

Date:	2022 - 2027
Title:	Metabolic imaging of patients with anaplastic thyroid cancer using hyperpolarized [1-13C]-pyruvate
Funding Source:	NIH/NCI
Role:	PI
ID:	1R01CA267827-01

Date:	2022 - 2027
Title:	Synthesis & Optimization of an Iron-Based, Targeted MRI Contrast Agent Platform
Funding Source:	NIH
Role:	Subcontract PI

Date:	2022 - 2027
Title:	Unraveling dynamic co-evolutions of brain metastasis and the unique brain microenvironment
Funding Source:	NIH/NCI
Role:	Core Co-Lead
ID:	1U54CA261702-01A1

Date:	2022 - 2026
Title:	Optimizing Precision Oncology Approaches with Hyperpolarized MRI in Head and Neck Cancer
Funding Source:	Cancer Prevention Research Institute of Texas
Role:	PI
ID:	RP220254

Date:	2021 - 2023
Title:	Targeting ONC201-insensitive DIPG tumor subpopulations
Funding Source:	Kure it Cancer Research
Role:	Co-PI
ID:	FP00014570

Date:	2021 - 2026
Title:	Medical Students Summer in Oncology at Anderson Research (Med Students SOAR) program
Funding Source:	NIH/NCI
Role:	Preceptor
ID:	1R25CA265800-01

Date:	2021 - 2026
Title:	Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer
Funding Source:	NIH
Role:	MPI
ID:	1R01DE031351-01

Date:	2021 - 2025
Title:	PASC Recovery Cohort
Funding Source:	University of Wisconsin
Role:	Co-I
ID:	FP00013473

Date:	2021 - 2024
Title:	Multimodal Theranostic Approach for Glioblastoma
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	CA200499

Date:	2021 - 2026
Title:	Unraveling dynamic co-evolutions of brain metastasis and the unique brain microenvironment
Funding Source:	NIH/NCI
Role:	Core Co-Lead
ID:	1U54CA261702-01

Date:	2021 - 2026
Title:	Multimodal Imaging and Therapy of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5R01CA255753-03

Date:	2021 - 2026
Title:	Imaging early lung and airway changes in ‘at risk’ young adults from the Lung Health Cohort
Funding Source:	University of Kansas
Role:	Subcontract Co-PI
ID:	FP10316_Res1

Date:	2021 - 2026
Title:	Imagingome for Prostate Cancer TSP
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA262113-01

Date:	2021 - 2026
Title:	MRI-guided Photothermal Therapy of Pancreatic Cancer with Gd2O3-MSNS
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA262001-01

Date:	2021 - 2023
Title:	An information-theoretic approach to HP signal acquisition in brain
Funding Source:	NIH/NCI
Role:	MPI
ID:	5R21CA249373-02

Date:	2021 - 2026
Title:	Theranostic Nanoparticles for Prostate Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA259598-01

Date:	2021 - 2026
Title:	Multifunctional Nanoparticle Imaging of Brain Tumors
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA259785-01

Date:	2021 - 2026
Title:	Prostate Cancer Imagingome
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA252361-01A1

Date:	2021 - 2023
Title:	T1-MRI Active Theranostic Gold Nanoshells for Guided Photothermal Therapy of Pancreatic Ductal Adenocarcinoma
Funding Source:	Rice/NIH
Role:	MPI

Date:	2020 - 2021
Title:	A mechanistic tumor growth model for HP MRI
Funding Source:	UTMDACC - ODEN
Role:	Co-PI
ID:	600651-30-123171-46

Date:	2020 - 2022
Title:	T1-MRI Active Theranostic Gold Nanoshells for Guided Photothermal Therapy of Pancreatic Ductal Adenocarcinoma
Funding Source:	Rice/NIH
Role:	MPI
ID:	FP00010483

Date:	2020 - 2025
Title:	Image Guided Cancer Therapy Training Program
Funding Source:	NIH/NCI
Role:	Mentor
ID:	1T32CA244131-01A1

Date:	2020 - 2025
Title:	Age-related normative lung and airway changes in young adults from the Lung Health Cohort
Funding Source:	University of Kansas/NIH
Role:	Co-PI

Date:	2020 - 2025
Title:	Imaging hepatic ketogenesis in NAFLD and NASH
Funding Source:	University of Florida/NIH
Role:	Principal Investigator-MDACC
ID:	R01DK105346

Date:	2020 - 2022
Title:	Multimodal Imaging and Therapy of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA255753

Date:	2020 - 2025
Title:	Nanomatryoshkas for Imaging and Therapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01EB029746-01A1

Date:	2020 - 2024
Title:	Noninvasive Modulation of Neural Circuits at the Microscale with Molecular, Cell-Type, and Temporal Precision
Funding Source:	Rice/NIH
Role:	Principal Investigator-MDACC

Date:	2020 - 2025
Title:	Prostate Cancer Imagingome
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA252361-01

Date:	2020 - 2025
Title:	Four-dimensional multiparametric and hyperpolarized MRI to investigate underlying mechanisms of radiation resistance in IDH wild-type glioma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA251590-01

Date:	2020 - 2025
Title:	UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
Funding Source:	NIH/NCI
Role:	Program Faculty
ID:	1R25CA240137-01A1

Date:	2020 - 2025
Title:	Developing Imaging-Pathologic Biomarkers in Treated Glioma
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI
ID:	RP200256

Date:	2020 - 2021
Title:	Tumor heterogeneity in immune sensitivity of DIPGs
Funding Source:	Chance for Life Foundation
Role:	Co-I

Date:	2020 - 2022
Title:	Multi-modal imaging to characterize the spatiotemporal evolution of thermochemical ablation
Funding Source:	SIR Foundation
Role:	Co-Mentor
ID:	FP 7108

Date:	2020 - 2025
Title:	Nanomatryoshkas for Imaging and Therapy
Funding Source:	NIH/NIBIB
Role:	Co-I
ID:	1R01EB029746-01

Date:	2020 - 2022
Title:	An information-theoretic approach to HP signal acquisition in brain
Funding Source:	NIH/NCI
Role:	MPI
ID:	1R21CA249373-01

Date:	2020 - 2025
Title:	Multimodal Theranostic for Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA247224-01A1

Date:	2020 - 2021
Title:	Enhanced selective internal radiation therapy based on remote control of individual radiation sources
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R21CA241837-01A1

Date:	2020 - 2024
Title:	High sensitivity 19F MRI for clinically translatable imaging of adoptive NK cell brain tumor therapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI
ID:	RP200223

Date:	2020 - 2022
Title:	Mark-III 129Xe Gas Polarizer System
Funding Source:	NIH/NCI
Role:	PI
ID:	1S10OD027038-01A1

Date:	2020 - 2023
Title:	NK Cell Therapy for Refractory or Relapsed Osteosarcoma
Funding Source:	UTMDACC - MRP
Role:	Co-I
ID:	No Assigned #

Date:	2020 - 2020
Title:	Immunotherapy approach for the treatment of Osteosarcoma
Funding Source:	Curing Kids Cancer
Role:	Co-I
ID:	No Assigned #

Date:	2019 - 2022
Title:	Dual-Mode Pre-Surgical and Surgical Imaging of Ovarian Cancer
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	OC180261

Date:	2019 - 2022
Title:	CAR-NK Adoptive Cell Therapy for Osteosarcoma
Funding Source:	MDACC - MRP
Role:	Project Leader - P2

Date:	2019 - 2024
Title:	Image Guided Cancer Therapy Training Program
Funding Source:	NIH/NCI
Role:	Mentor
ID:	1T32CA244131-01

Date:	2019 - 2024
Title:	The Stereotactic RadPath Study: Imaging-Pathologic correlations in Glioma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA245012-01

Date:	2019 - 2024
Title:	Multimodal Theranostic for Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA247224-01

Date:	2019 - 2021
Title:	Characterization of the 3D spatio-temporal evolution of thermochemical ablation using advanced imaging methods
Funding Source:	SIR Foundation
Role:	Collaborator
ID:	No Assigned #

Date:	2019 - 2024
Title:	High sensitivity 19F MRI for clinically translatable imaging of adoptive NK cell brain tumor therapy
Funding Source:	NIH/NCI
Role:	PI
ID:	1R01CA240421-01

Date:	2019 - 2021
Title:	Enhanced selective internal radiation therapy based on remote control of individual radiation sources
Funding Source:	NIH/NCI
Role:	MPI
ID:	1 R21 CA241837-01

Date:	2019 - 2024
Title:	Mechanism of regulation of cancer metabolism by non-coding RNA structure
Funding Source:	NIH/NCI
Role:	Other Significant Contributor
ID:	1R01CA235803-01A1

Date:	2019 - 2024
Title:	UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
Funding Source:	NIH/NCI
Role:	Program Faculty
ID:	1R25CA240137-01

Date:	2019 - 2024
Title:	Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5R01CA231149-05

Date:	2019 - 2021
Title:	Pilot Study of Metabolic Guidance for Radiation Therapy in Patients with Head & Neck Cancer
Funding Source:	UTMDACC - CABI
Role:	MPI
ID:	CABI CP3

Date:	2019 - 2024
Title:	Multimodal Imaging and Therapy of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA235582-01A1

Date:	2019 - 2024
Title:	Systemic tumor immunity via image-guided intratumoral drug delivery
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA239037-01

Date:	2019 - 2024
Title:	Measuring Extracellular pH in Pre-clinical Tumor Models with acidoCEST MRI
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA236870-01

Date:	2019 - 2022
Title:	Theranostic Nanoparticle for Ovarian Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP190294

Date:	2019 - 2020
Title:	Mark-III 129Xe Gas Polarizer System
Funding Source:	NIH/NIGMS
Role:	PI
ID:	1S10OD027038-01

Date:	2019 - 2019
Title:	Efficacy of Immunotherapy combination for the treatment of Osteosarcoma
Funding Source:	Curing Kids Cancer
Role:	Co-I

Date:	2018 - 2020
Title:	Advancing 19F MRI NK Cell Tracking Probes using Amphiphilic Peptide Platform
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R21CA235593-01

Date:	2018 - 2023
Title:	Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients
Funding Source:	NIH/University of California - San Francisco
Role:	Co-I
ID:	U01CA232320-01

Date:	2018 - 2020
Title:	MRI imaging of adoptive NK cell immunotherapy
Funding Source:	UTMDACC
Role:	Collaborator
ID:	IRG

Date:	2018 - 2023
Title:	Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA231149-01

Date:	2018 - 2023
Title:	Multimodal Imaging and Therapy of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1 R01 CA235582-01

Date:	2018 - 2023
Title:	Mechanism of regulation of cancer metabolism by non-codingRNA structure
Funding Source:	NIH/NCI
Role:	Other Significant Contributor
ID:	1R01CA235803-01

Date:	2018 - 2019
Title:	Validation of optoacoustic probe and development of oxygen-sensitive nanoparticle contrast agents for real-time quantitation of utero-placental oxygenation: Influence of smoking on fetal hypoxia
Funding Source:	University of Texas Medical Branch at Galveston/NIH
Role:	Co-I

Date:	2018 - 2022
Title:	Imaging of Natural Killer Cell Immunotherapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	P2-Project Leader
ID:	RP180777

Date:	2018 - 2018
Title:	NMR Antennas for 13C Imaging of Human Head and Neck
Funding Source:	Berkshire Magnetics LLC
Role:	Co-I
ID:	1R43EB025711-01A1

Date:	2018 - 2023
Title:	Measuring extracellular pH in pre-clinical tumor models with acidoCEST MRI
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA227267-01A1

Date:	2018 - 2021
Title:	Quantitative Science at MD Anderson Cancer Center
Funding Source:	National Science Foundation (NSF)
Role:	Mentor

Date:	2018 - 2021
Title:	Presurgical and Surgical Imaging to Improve Outcome for Patients with Ovarian Cancer
Funding Source:	Department of Defense (DOD)
Role:	Co-I

Date:	2018 - 2020
Title:	Dual mode imaging to improve surgical outcomes for brain tumors
Funding Source:	Department of Defense (DOD)
Role:	Co-I

Date:	2018 - 2023
Title:	Dual Mode Dual Gd for both Pre-surgical and Surgical Imaging of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA208234-01A1

Date:	2018 - 2023
Title:	The role of stratifin as an upstream regulator in cancer cell metabolism
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA226290-01

Date:	2018 - 2021
Title:	Dual Mode Dual Gd for Both Pre-Surgical and Surgical Imaging of Ovarian Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2017 - 2019
Title:	A Hyperpolarized Pyruvate MR Spectroscopy Imaging Trial for Glioma Patients: An Exploratory First Study at M D Anderson
Funding Source:	NIH/NCI
Role:	Co-I
ID:	P50CA127001

Date:	2017 - 2022
Title:	Nano Solutions for Overcoming Stromal Barriers in PDAC
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1U01CA218301-01

Date:	2017 - 2018
Title:	Development of dual-frequency radiofrequency antennas for magnetic resonance imaging and spectroscopy of hyperplarized 13C in human head and neck
Funding Source:	Berkshire Magnetics
Role:	Co-I
ID:	1R43EB025711-01

Date:	2017 - 2022
Title:	Treatment Progression Stage Imaging of Prostate Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA216434-01A1

Date:	2017 - 2019
Title:	The Neuron-Astrocyte Dyad, the Lactate Shuttle and Metabolic Brain Imaging with Hyperpolarized MR
Funding Source:	NIH/NCI
Role:	MPI
ID:	1R01EB025130-01

Date:	2017 - 2019
Title:	Development of multi-parametric magnetic resonance imaging into a predictive imaging biomarker of radiation response
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R21CA218370-01

Date:	2017 - 2022
Title:	Standardized Quantitative Imaging Biomarkers for Co-Clinical Trials
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1U24CA220280-01

Date:	2017 - 2022
Title:	Modeling and constrained reconstruction strategies for imaging tumor metabolism with hyperpolarized pyruvate
Funding Source:	NIH/NCI
Role:	PI
ID:	1R01CA208041-01A1

Date:	2017 - 2022
Title:	Pre-surgical and Surgical Imaging of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA220383-01

Date:	2017 - 2022
Title:	Optimizing Chemoradiation Strategies Through Interrogation of Tumor Metabolism
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA207278-01A1

Date:	2017 - 2025
Title:	Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
Funding Source:	NIH/NCI
Role:	PI
ID:	5R01CA211150-05

Date:	2017 - 2019
Title:	Time Reversal Based Radio-Frequency Antenna System for Non-Invasive Thermal Cancer Therapy
Funding Source:	University of Houston/CPRIT
Role:	Co-I
ID:	RP160414

Date:	2016 - 2020
Title:	Optimizing Chemoradiation Strategies by Tumor Metabolism Interrogation
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP170366

Date:	2016 - 2019
Title:	Quantitative Preclinical Metabolic MRI using hyperpolarized substrates
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	RP170202

Date:	2016 - 2018
Title:	A sparse reconstruction algorithm for superparamagnetic relaxometry
Funding Source:	NIH/NCI
Role:	Dissertation Advisor
ID:	5F31CA210434-02

Date:	2016 - 2024
Title:	NO TITLE PROVIDED
Funding Source:
Role:

Date:	2016 - 2017
Title:	Functional and Metabolic Imaging Biomarkers of Radiation Response in High-Risk HPV+ Tumors
Funding Source:	Radiological Society of North America (RSNA)
Role:	Co-I

Date:	2016 - 2022
Title:	Imaging hepatic gluconeogenesis with hyperpolarized dihydroxyacetone
Funding Source:	NIH/NIDDK
Role:	Subcontract PI
ID:	5R01DK105346-05

Date:	2016 - 2019
Title:	Improving head and neck carcinoma radiation therapy through preclinical integration of genomics
Funding Source:	UTMDACC Multidisciplinary Research Program
Role:	Co-I
ID:	Coeus Proposal #18802

Date:	2016 - 2021
Title:	MR Imaging of Natural Killer Cell Immunotherapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	2016-RP160738-Y1

Date:	2016 - 2021
Title:	Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	5R01DE025248-04

Date:	2016 - 2018
Title:	Imaging- Based Quantitative Analysis of Vascular Perfusion and Tissue Oxygenation to Improve Therapy of Liver Cancer
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	CA150140

Date:	2016 - 2019
Title:	Imaging- Based Quantitative Analysis of Vascular Perfusion and Tissue Oxygenation to Improve Therapy of Hepatocellular Carcinoma
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP160229

Date:	2016 - 2018
Title:	Development of unconventional MRI approaches to imaging cancer immunotherapy
Funding Source:	UTMDACC/GE Healthcare
Role:	Co-I
ID:	CABI MI2

Date:	2015 - 2019
Title:	Joint HP/MR/PET for Quantitative Measurement of Tumor Metabolism
Funding Source:	UTMDACC/GE Healthcare
Role:	PI

Date:	2015 - 2016
Title:	Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1R56DE025248-01

Date:	2015 - 2020
Title:	Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
Funding Source:	NIH/NCI
Role:	Mentor
ID:	5T32CA196561-05

Date:	2015 - 2017
Title:	Multimodal Nanoagent for Guidance and Imaging of Cancer Immunotherapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R21CA201801-01

Date:	2015 - 2019
Title:	Model-based reconstruction and analysis of hyperpolarized pyruvate
Funding Source:	NIH/NHLBI
Role:	PI
ID:	NIH 1R01 EB018972-01A1

Date:	2015 - 2017
Title:	Radial Spectroscopic Imaging of Hyperpolarized [1-13C]-Pyruvate
Funding Source:	UTMDACC/GE Healthcare
Role:	PI
ID:	WS#16

Date:	2015 - 2020
Title:	The regulation of MYC gene family in cancer cell metabolism
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI

Date:	2015 - 2020
Title:	Physical dynamics of the Tumor-Host Interaction (Project 3)
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2015 - 2016
Title:	PQC4: Tumor Microenvironmental Phenotyping by Multiparametric MRI
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2014 - 2017
Title:	Targeting tumor metabolism with glucose-based therapeutic agents and monitoring treatment response with hyperpolarized MR Spectroscopy
Funding Source:	Dr. Marnie Rose Foundation
Role:	Co-PI

Date:	2014 - 2017
Title:	Inhibiting Oxidative Phosphorylation: A Novel Strategy in Leukemia
Funding Source:	NIH/NCI
Role:	Co-I
ID:	RP140218

Date:	2014 - 2017
Title:	Optimizing radiosensitization in anaplastic thyroid cancer with metabolic imaging
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5 R21 CA178450-02

Date:	2014 - 2016
Title:	P5: Novel MRI and MRS Methods for Imaging Cancer Metabolism
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	RP140021-P5

Date:	2013 - 2019
Title:	Cancer Center Support (Core) Grant
Funding Source:	NIH/NCI
Role:	Co-Director
ID:	5P30CA016672-42

Date:	2012 - 2013
Title:	Real-time assessment of enhanced permeability and retention dynamics in tumors using magnetic nanoparticles
Funding Source:	NIH/NCI
Role:	Co-PI

Date:	2012 - 2013
Title:	Novel Imaging Agents to Expand the Clinical Toolkit for Cancer
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	261201200058C-0-0-1

Date:	2011 - 2016
Title:	T-Cell therapy after hematopoietic stem cell transplantation
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP120241

Date:	2011 - 2017
Title:	Personalizing Nanoparticle Therapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5R01 CA159042 05

Date:	2010 - 2013
Title:	Novel MRI and MRS Methods for Imaging Cancer Metabolism
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI
ID:	RP101243

Date:	2010 - 2014
Title:	P5: Fast Imaging Methods for Hyperpolarized Nuclei
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	RP101243-P05

Date:	2009 - 2013
Title:	ARHI (DIRAS 3) in Autography and Dormancy of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	5R01CA135354-02

Date:	2008 - 2013
Title:	Novel Targets for Treatment and Detection of Inflammatory Breast Cancer
Funding Source:	Susan G. Komen Breast Cancer Foundation
Role:	Co-I
ID:	KG081287-03

Date:	2008 - 2011
Title:	Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R21 CA135315 01

Date:	2008 - 2009
Title:	Multi-Animal Simultaneous PET-MR Imaging
Funding Source:	IRG Basic Research
Role:	Collaborator

Date:	2008 - 2013
Title:	Cancer Center Support (Core) Grant
Funding Source:	NIH/NCI
Role:	Core Resource Co-Director
ID:	P30 CA016672-34

Date:	2008 - 2009
Title:	Novel In-Vivo Imaging Of Tumor Vascular Structure And Function In Preclinical Models of Ovarian Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	5 P50 CA083639

Date:	2007 - 2012
Title:	Experimental Cancer Imaging Research Program (ECIRP)
Funding Source:	NIH/NCI
Role:	Core Leader
ID:	U24 CA 126577

Date:	2007 - 2010
Title:	Molecular and Functional Magnetic Resonance Imaging
Funding Source:	Department of Defense (DOD)
Role:	Collaborator
ID:	W81XWH-07-1-0018 01

Date:	2006 - 2009
Title:	Alliance for NanoHealth Seed Grant Projects
Funding Source:	Department of Defense (DOD)
Role:	Collaborator

Date:	2006 - 2013
Title:	Medical Physics Training Grant for Image-Guided Therapy Research
Funding Source:	NIH/NCI
Role:	Mentor
ID:	T32CA119930-04

Date:	2005 - 2006
Title:	Multifunctional Nanoparticles for MRI and Optical Imaging
Funding Source:	Career Dev. Award
Role:	Co-I
ID:	P50 CA070907-08

Date:	2005 - 2010
Title:	UTMDACC SPORE in Ovarian Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	5 P50 CA083639 09

Date:	2005 - 2010
Title:	UTMDACC Startup Funds
Funding Source:	UTMDACC
Role:	Principal Investigator-MDACC

Date:	2004 - 2006
Title:	Array Detectors for Accelerated Small Animal MRI
Funding Source:	NIH
Role:	PI
ID:	R21 CA110181

Date:	2004 - 2005
Title:	Technology Development for Multiple-Animal MRI
Funding Source:	UTMDACC Institutional Research Grant (IRG)
Role:	PI

Date:	2002 - 2004
Title:	University of Texas MD Anderson Spore in Ovarian Cancer
Funding Source:	NIH
Role:	Collaborator
ID:	P50 CA083639

Date:	1998 - 2003
Title:	Interactive Image Guided Closed Loop Thermal Therapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R44 CA079282

Title:	Robust Platform for Quantitative Preclinical Multi-Animal Imaging
Funding Source:	NIH/NCI
Role:	PI
ID:	R01 CA168980

Title:	Compact Permanent-Magnent MRI system for us in barrier facility
Funding Source:	NIH/NCI
Role:	PI
ID:	S10RR033008

Title:	7T Biospec Small Animal MRI/MRS System
Funding Source:	NIH/NCI
Role:	PI
ID:	S10OD918496

Title:	Magneto-plasmonic nanoparticles for adaptive immunotherapy guidance and monitoring
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator

Title:	Using Real-Time Metabolic Imaging to Develop Solid Tumor Adapitive Irradiation
Funding Source:	NIH/NCI
Role:	Co-I
ID:	CA184773

CV information above last modified June 16, 2025

James A. Bankson, Ph.D.

About Dr. James A. Bankson

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Abstracts

Book Chapters

Patents

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

James A. Bankson, Ph.D.

About Dr. James A. Bankson

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Abstracts

Book Chapters

Patents

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer